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Neurological disorders require varying types and degrees of treatments depending on the symptoms
and underlying causes of the disease. Patients suffering from medication-refractory symptoms of-
ten undergo further treatment in the form of brain stimulation, e.g. electroconvulsive therapy
(ECT), transcranial direct current stimulation (tDCS), deep brain stimulation (DBS), or transcra-
nial magnetic stimulation (TMS). These treatments are popular and have been shown to relieve
1
various symptoms for patients with neurological conditions. However, the underlying effects of the
stimulation, and subsequently the causes of symptom-relief, are not very well understood. In par-
ticular, TMS is a non-invasive brain stimulation therapy which uses time-varying magnetic fields
to induce electric fields on the conductive parts of the brain. TMS has been FDA-approved for
treatment of major depressive disorder for patients refractory to medication, as well as symptoms
of migraine. Studies have shown that TMS has relieved severe depressive symptoms, although re-
searchers believe that it is the deeper regions of the brain which are responsible for symptom relief.
Many experts theorize that cortical stimulation such as TMS causes brain signals to propagate from
the cortex to these deep brain regions, after which the synapses of the excited neurons are changed
in such a way as to cause plasticity. It has also been widely observed that stimulation of the cortex
causes signal firing at the deeper regions of the brain. However, the particular mechanisms behind
TMS-caused signal propagation are unknown and understudied. Due to the non-invasive nature
of TMS, this is an area in which investigation can be of significant benefit to the clinical commu-
nity. We posit that a deeper understanding of this phenomenon may allow clinicians to explore
the use of TMS for treatment of various other neurological symptoms and conditions. This thesis
project seeks to investigate the various effects of TMS in the human brain, with respect to brain
tissue stimulation as well as the cellular effects at the level of neurons. We present novel models
of motor neuron circuitry and fiber tracts that will aid in the development of deep brain stimulation
modalities using non-invasive treatment paradigms.
2
.Introduction
4.1 Human Brain Physiology
Figure 1: Brain Cortex with highlighted Primary Motor Cortex and Dorsolateral Prefrontal Cortex.
[1]
The human brain is an exceedingly complex structure, with an estimated 100 billion neurons, and
each neuron maintaining thousands of connections with surrounding neurons.[34]. These neurons
are susceptible to many different variations of disease and disorder. To date neuroscience research
has found numerous methods to treat patients of neurological disease. [35] [36] [37] In general, the
following information about the human brain has been established. The outer layer of the brain,
called the cortex, contains neuron bodies and is known as grey matter. Underneath the grey matter
lie the axons of the neuron bodies with a fatty covering which appears white in color; for this reason
the tissue is called the white matter. Furthermore, the human brain cortex is divided into several
lobes, each of which retains primary responsibilities. Each specific action is of course governed
by very refined areas of the brain, but within each lobe, neurons generally perform similar types of
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tasks. [38] TMS experts are mainly concerned with the frontal lobe, which contains the motor con-
trol area and is also responsible for many complex tasks including mood and personality.[37] [39]
[40] Specifically, we target the Dorsolateral Prefrontal Cortex (DLPFC) and the Primary Motor
Cortex (PMC), both of which are shown in Figure 1.
Although we divide the brain into primary lobes for purposes of simplification, in reality most
tasks require the use of multiple cortical regions as well as deep brain nuclei. [41] [42] [43] The
structure of the human brain can be best understood by following its progress through fetal de-
velopment. The brain is first developed in parts called the forebrain (prosencephalon), midbrain
(mesencephalon), and hindbrain (rhombencephalon). Later in development, these structures dif-
ferentiate into a total of five structures called the telencephalon, diencephalon, mesencephalon,
metencephalon, and myelincephalon. [44] [45] [46] Gestational progress can be seen in Figure 2.
Figure 2: Human brain development from conception to birth. [2]
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Because of the exceedingly complex nature of the human brain, it is important to study in detail
its structure and function in order to make clinical progress. However, in vivo studies are difficult
to perform, even if scientists are able to receive permissions and funding. With such restrictions,
it is tempting to perform parallel studies on animals whose brain structures resemble ours. While
it is possible to draw some conclusions about the human brain as a result of animal studies, there
are many significant characteristics which are unique to the human brain. Figure 3 shows major
differences between animal and human brain structure.
Figure 3: Evolutionary differences in brain structure between primates and humans.[3]
5
Due to these significant differences, it is important to study the human brain to the deepest extent
possible, and for this we use computational models and simulations. Simulations performed on
human brain models can provide results which are good first steps for many neurological studies.
It is our hope that the models and simulations presented in this thesis will add value to the clinical
neurological realm.
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4.2 Magnetic Resonance Imaging (MRI)
MRI is a widely-used imaging technique in clinical settings around the world. The technology
is ubiquitous due to its non-invasive nature, consequent safety, and high-resolution image quality.
MRI is made possible by the use of spins in unpaired protons, specifically in hydrogen atoms in
the body (water). The spin of a proton in a Hydrogen atom precesses about an external magnetic
field at the Larmor frequency, which can be described as follows:
f = γB (1)
where γ is the gyromagnetic ratio of the tissue in MHz/Tesla.
MRI is based on the concept of a spatially varying magnetic field creating spacially varying preces-
sion at the Larmor frequency. Separating the frequency components across the objects gives spatial
information. For MRI, we use bulk precession of the water, fat, and other tissues. The consequent
magnetization due to this precession is measured by a receive coil in the MRI machine. [47]
Resonance in MRI refers to matching a radiofrequency (RF) signal of an oscillating magnetic field
to the precession frequency of nuclear spin. An overview of the scanner is shown in Figure 4.
Magnetic moments of neutron and protons in the nucleus cancel out when the number of neutrons
is equal to the number of protons, and this number is even. For unpaired protons, the magnetic
moments do not exactly cancel. Only molecules whose nuclei have a net magnetic moment are
able to interact with MRI magnetic fields. [48]
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Figure 4: A broad view of the MRI scanner and its multiple coils which generate not only a gradient
magnetic field, but also an RF wave and a receiver coil. [4]
If rotation or spin is a first order quantity of angular momentum, and precession is the second-
order quantity, then the third-order quantity is nutation, which results from forces rotating with the
body’s precession. Nutation changes the angle of the object’s precession. For example, consider a
precessing spinning top, and a finger pushing this top at a certain point with a certain frequency, to
change the angle of the top’s precession. In MRI, a time-varying magnetic field causes nutation in
biological tissue.
Static B-fields in MRI at 0.1 – 3 T correspond to 4.3 – 129 MHz Larmor frequency (precession)
in hydrogen protons. Time-varying B-field on order of MHz cause nutation. Resonance happens
when this frequency matches precession frequency of protons in a certain static magnetic field.
These frequencies are typically on the order of radio-frequencies, so we use RF waves in MRI.
Furthermore, the receiver coil generally only picks up precession wavelengths on the plane trans-
verse to itself, so it is important to cause precession in the body on that particular plane.
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When an RF wave is applied to a sample at the resonance frequency, the bulk magnetization pre-
cesses at the Larmor frequency. The intensity and time of RF radiation determines the precession
angle. In this way, the RF pulse is used to bring a large number of protons in a sample in phase
with each other, and this increases the bulk magnetization by aligning all the spins in the tissue.
Thus, a magnetization can be applied from the sample onto the receiver coil in the transverse plane.
Therefore, the static magnetic field aligns all protons in same direction, in the direction of the
applied magnetic field. The addition of an RF pulse, created using a time-varying magnetic field,
causes synchronized precession among all the protons in a plane (or slice) which causes a large
magnetization transverse to the receive coil. This process is shown in Figure 5.
Figure 5: Process of MRI magnetization and how it effects proton spins and resonance. [5]
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Switching off the RF pulse causes the protons to relax back into their original state of alignment
with static magnetic field. This is called longitudinal or spin-lattice relaxation. It is also referred
to the T1 relaxation time. T2 relaxation happens when the protons relax into their unsynchro-
nized random precession. This is called spin-spin relaxation. Both T1 and T2 relaxation happen
simultaneously, although T2 time is generally shorter than T1.
Different biological materials have varying T1 and T2 relaxation times. The difference between
these times can be used to differentiate between different materials in the body. The reasons
for differing relaxation times between materials are complex, but one factor is material viscosity.
Molecules with slow-rotating spins have a greater chance for interacting with their neighbors, thus
shortening their relaxation time.Furthermore, molecules with spins that happen to be rotating at
the Larmor frequency have the minimum T1 relaxation times. Water molecules in different tissues
have different T1 relaxation times, but often these T1 times are too long to give meaningful contrast
in images. For this reason, we use contrast agents.
Fiber Tracts
Signals typically begin in one area of the brain and propagate through certain pathways, including
cortical and deep brain regions. [49] However, many of these paths are not very well understood
and difficult to study. Specific areas of the brain have been mapped out for research into certain
neurological conditions, such as the hippocampus for memory deficits and the motor pathway for
motor symptoms. [50] [51] [24] [52]
With new innovations in Magnetic Resonance Imaging (MRI), this infrastructure is now observ-
able through fiber tracts, which allow visualization of the white matter fibers within the brain.
Fiber tracts are visualized by using Diffusion Tensor Imaging (DTI), in which diffusion of water
molecules is mapped, thus marking the direction and pathways of axons. [53]
In Diffusion MRI, the diffusion coefficient (the relationship between diffusive flux and concentra-
tion gradient) is found by using six different diffusion gradients, and the water molecule diffusion
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is then modeled as a Gaussian distribution. Diffusion of water molecules in the brain is anisotropic,
and so the gradient allows tracking of these pathways. The diffusion tensor is a 3x3 symmetric,
positive-definite matrix. Principal direction of each tensor determines the axon’s direction, or the
direction in which the water molecules diffuse fastest. The subsequent fibers are tracked through-
out the 3D space of the brain.[54] [55] [56] [53] One major limitation, however, is that DTI is
unable to track crossing fibers. [57] [58] [59]
Figure 6 shows a fiber tract image extracted from a functional MRI (fMRI) using DTI.
Figure 6: Fiber Tract data visualization created using DTI.[6]
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4.3 Neuron Signal Processes
It is hypothesized that the adult human brain is composed of 80 to 100 billion neurons, each of
which makes thousands of connections to neighboring neurons.[60][61] Furthermore, there are
hundreds of neuron types with varying physiology and functions.[62] Consequently, it is an ex-
tremely complex and computationally intensive task to attempt to model the entire human brain.
For this reason, single neuron and neural network models generally focus on small geometric areas
of the brain with a single neuronal type. Due to the nature of the diseases we are attempting to
study, we will focus on certain neuronal circuitries using the standard neuron model, from which
few neuronal types deviate. It is shown is Figure 7.
Figure 7: Neuron Anatomy [7]
The soma, or cell body, receives electrical signals which pass through the long spine, or axon, and
exit via the synaptic terminals.[63] The physical location where a signal is passed from one cell
to the other is known as a synapse, and the impulse passes from the pre-synaptic neuron to the
post-synaptic neuron. Interestingly, it is not the electrical signal that is passed between neurons,
but rather chemicals known as neurotransmitters which are released from the synaptic terminals
of the pre-synaptic cell due to electric stimulation. Depending on the signal, certain ion channels
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open, and the neurotransmitters then activate the receptors of the post-synaptic cell, which incites
a new electrical signal within the body of the post-synaptic neuron. [64]
There are two general types of signals: excitatory, in which the neurotransmitter released excites
the post-synaptic neuron, thus increasing the chances of neuron firing, and inhibitory, in which the
neurotransmitter inhibits signal induction in the post-synaptic neuron. Although many synaptic
connections in the brain are excitatory, it is crucial to also include inhibitory connections in order
to prevent cascade effects of signal propagation, leading to over-activity in the brain. In fact, it is
hypothesized that this cascade effect in the absence of enough inhibition is the cause of epileptic
seizures, in which large parts of the brain begin firing in synchrony.[65] The type of signal received
is dependent upon the neurotransmitter residing in that particular synapse as well as the frequency
of the signal in the pre-synaptic cell. One of the most common excitatory neurotransmitter is
glutamate, whereas the inhibitory chemical is usually gaba-Aminobutyric acid, commonly referred
to as GABA. Dopamine can induce either excitatory or inhibitory signals, depending upon the type
of receptor being targeted. [66]
Importantly, it is not enough for the soma to simply receive one or even several signals; at any
given time, all input signals (excitatory and inhibitory) must sum to exceed what is called the
action potential. At rest, the neuron remains at -70 mV. This voltage may increase as the soma
receives signals at varying times, but the neuron will not fire until a voltage of -55 mV is reached.
It is only at this point that the signal will exit the soma and travel down the axon and through
the synaptic terminal. This is called the action potential, and the process is shown in Figure 8.
Importantly, single signals cause very little potential change; in general one neurons typically
requires thousands of signals to reach its action potential. [67]
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Figure 8: Action Potential [8]
All neurons do not fire at the same frequency or rhythm. Various types of cells experience acti-
vation differently. At any given time, most neurons maintain some firing even in the absence of
specific stimulation. We consider these signals as background noise, wherein the cell fires consis-
tently without any task input; background firing can be regular or irregular, tonic (irregular pattern)
or bursty (several spikes one after another followed by periods of inactivity). [68] [69]
Neuron firing is often shown as voltage spiking in the part of the brain which is being recorded.
Figure 9 shows voltage differences between tonic firing and burst firing. In contrast, phasic fir-
ing occurs only when the neuron receives presynaptic input which reaches or exceeds the action
potential. Phasic firing can also be bursty or tonic, depending on the incoming signal. [68] [69]
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Figure 9: Excitatory post-synaptic potentials (EPSPs) in subthalamic nucleus. Note the difference
in firing pattern between tonic firing and burst firing.[9]
Motor Pathway
We will be looking at some smaller nuclei in deeper regions in the brain, primarily the set of
nuclei known as the Basal Ganglia (BG), the dysfunction of which is involved in motor disorders
such as Parkinson’s Disease. Within the Basal Ganglia there exist the striatum, the globus pallidus
internus (GPi), globus pallidus externus (GPe), substantia nigra, and subthalamic nucleus (STN),
and thalamus. The neuron pathways between the basal ganglia, thalamus and cortex with respect
to motor function is well-studied and modeled. One such model is outlined in Figure 10.
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Figure 10: Pathways between cortex, basal ganglia and thalamus. Note the various inhibitory (-)
and excitatory (+) synapses at different locations. [10]
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There are two paths to observe in this paradigm. The direct pathway starts from the cortex, at the
moment of movement initiation, from where an excitatory signal is passed to the striatum, which
also receives dopaminergic signals from the substantia nigra pars compacta. The striatum then
passes inhibitory signals to the GPi, which goes on to inhibit the ventral anterior and ventral lateral
nuclei (VAVL) of the thalamus. From there, excitatory signals are passed to the motor areas of the
cortex, and movement occurs.[33] [70] Due to the complex nature of this circuit, it is important to
understand the role of the GPi, particularly the nature of the inhibitory signals. In a healthy brain,
firing of the VAVL neurons leads to movement. However, in the absence of movement initiation,
the VAVL is inhibited by the tonic irregular firing of the GPi - this process prevents unwanted
movement from occurring. When a motor process is initiated, the striatum inhibits the GPi, and
the lack of GPi firing then allows the VAVL to fire and cause movement. This process is called
movement by disinhibition. [71] [70] It is important to note that the motor pathway does not only
allow for normal movement, but also inhibition of movement at rest. We are interested in exploring
this pathway at rest for the treatment of resting tremor and muscle rigidity.
One of the foci of this project is Parkinson’s Disease (PD), which is characterized by intense
muscle stiffness and a shuffling walk as well as resting tremor. [72] A common treatment for these
symptoms is Deep Brain Stimulation (DBS), in which a probe is surgically inserted into the BG
and direct current is applied continuously to either the GPi or the STN. [73]
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4.4 Short History of Bioelectrical Stimulation
Around 46-47 AD, the Roman emperor Claudius’ court physician, Scribonius Largus, inscribed
hundreds of treatments to common ailments. [74] One of these treatments was the application of
a fish, known as the electric ray, to the head for headache relief. [75] These fish were known to
discharge electricity, and later on were also used on patients’ scalps to relieve symptoms of seizure,
depression and pain. [76] [35]
In the 18th century, Luigi Galvani, a prominent scientist, showed that muscles in dead frogs could
be made to move by electrically stimulating the nerves. [77] Galvani believed that there was
electricity intrinsic to an animal’s nerves, and he called this phenomenon animal electricity. From
these and other experiments, Galvani became the pioneer for bioelectromagnetics. His name is
used today for terms such as galvanic cell and galvanic skin response (GSR).
In the 19th century, German neurologist Gustav Fritsch and anatomist Eduard Hitzig together used
electrical stimulation in the motor cortex of a dog to excite the dog’s muscles. By applying an
electrode directly to the exposed motor cortex of the dog’s brain, they found that different cortical
regions affected various parts of the body.[78]
In the 1900’s, Sir Alan Hodgkin and Sir Andrew Fielding Huxley, both physiologists and bio-
physicists, developed the action potential theory which explained the initiation and propagation of
neuron signals. [79] Together, they developed the Hodgkin-Huxley model of the neuron, which
even today is a fundamental model for understanding the neuron. In 1963, they were awarded the
Nobel Prize in Physiology for their work in neurology. Today, many computational and mathemat-
ical models of neurons and neuron networks are built on the foundation of the Hodgkin-Huxley
neuron model.
These events, and more, are detailed in Figure 11, which shows some significant events in the
bioelectrical realm.
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Figure 11: Timeline of significant historical events and notable scientists in the field of bio-
electricity. [11]
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4.5 Brain Stimulation Modalities
To date, multiple brain stimulation techniques have become available for patients of neurological
disease, including vagus nerve stimulation, transcranial direct-current stimulation (tDCS), electro-
convulsive therapy (ECT, also known as Shock Therapy), transcranial magnetic stimulation (TMS)
and deep brain stimulation (DBS).
4.6 Vagus Nerve Stimulation (VNS)
The Vagus nerve, or Cranial nerve X, is a pair of nerves, one on each side of the body, which runs
from the brainstem to the heart, lungs, and digestive tract. During Vagus Nerve Stimulation, or
VNS, electrodes are implanted which stimulate the vagus nerve. [80] VNS is FDA-approved for
treatment of partial-onset seizures which are refractory to medication. VNS works by delivering
current to the brain via the Vagus nerve. However, the exact mechanism by which VNS controls
seizures is not very well understood. Figure 12
Figure 12: Vagus Nerve Stimulation. [12]
20
4.7 Transcranial Direct-Current Stimulation
tDCS uses low-amplitude DC current in electrodes which are placed on the patients head, as shown
in Figure 13.
Figure 13: Schematic of transcranial direct-current stimulation. [13]
tDCS is relatively cheap, easy to administer, and causes minimal side effects. However, it induces
spontaneous neuron firing rather than synchronous action potentials, and so may not be as effective
as other neurostimulation techniques. Additionally, due to the nature of electrode placement during
tDCS, current is delivered over a widespread area of the scalp rather than a small targeted region
of the brain. Therefore, it is difficult to target the deficient nucleus or cortical area. [81]
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4.8 Electroconvulsive Therapy
During ECT, grand-mal seizures are induced by applying high-amplitude current directly to the
patient’s head. ECT has shown beneficial effects for 50% of patients of Major Depressive disorder.
However, ECT requires general anesthesia, and patients have to undergo several sessions, after
which they only have a 50% chance of success. Figure 14 shows a schematic of the process. [82]
Figure 14: Schematic of electroconvulsive therapy.
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4.9 Deep Brain Stimulation
Patients with PD suffer from multiple symptoms including bradykinesia, resting tremor, shuffling
gait, and muscle rigidity, along with non-motor symptoms including speech and swallowing diffi-
culties. [72] [83] [84] Symptoms often respond to Levodopa (L-dopa), a dopaminergic medication.
However, symptoms can often become refractory, or the medication causes side effects. [85] [86]
[87] Patients will then undergo deep brain stimulation (DBS) surgery, wherein electrical leads de-
liver current directly onto deep brain nuclei called the basal ganglia. [88] [73] [89] DBS is widely
used to improve motor symptoms in PD and Essential Tremor (ET) patients. [88] [73] [90] Figure
15 shows DBS leads inserted into the brain. DBS is a highly effective technique, but can only tar-
get deep brain nuclei which must be mapped in advance. DBS also requires invasive initial surgery
for lead implantation, as well as further surgery to change the battery pack, all of which may lead
to surgical complications.
Figure 15: Schematic image of Deep Brain Stimulation. [14]
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4.10 Transcranial Magnetic Stimulation
In 1985, Barker et. al introduced Transcranial Magnetic Stimulation (TMS) in The Lancet by
showing the effect of a magnetic field on the motor cortex. [91] TMS is a non-invasive brain
stimulation technique which is currently FDA-approved for treatment of Major Depressive disorder
and is under investigation for potential treatment of other neurological conditions. It is also widely
used as a diagnostic technique as well as a brain mapping tool. [92] [93] Today, there are multiple
companies creating TMS devices for clinical treatment of patients. Figure 16 shows the TMS
device developed by Neuronetics, Inc.
Figure 16: NeuroStar TMS device.[15]
During TMS, alternating current is pumped through a figure-of-8 coil, shown in Figure 17. The
consequent time-varying magnetic field induces an electric field on the conductive tissues of the
brain, thus stimulating the targeted region of the cortex. Furthermore, the brain tissue can be
excited or inhibited by varying the pulse frequency of repetitive TMS (rTMS).[93] rTMS for treat-
ment of depression targets the dorsolateral prefrontal cortex (DLPFC) and is shown to be effective
in patients for which other treatments such as medication are ineffective.[94]
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Figure 17: Transcranial Magnetic Stimulation [16]
rTMS treatment for depression typically begin with single pulse TMS near the hand area of the
motor cortex. The physician finds the corresponding scalp region when the patient’s thumb visibly
twitches, then places the TMS coil 5 cm anterior, to stimulate the DLPFC. The device is then set
to stimulate using pulse trains of 10 pulses per second for 30 minute sessions, 5 days/week for 4-6
weeks.[95] [96]
The magnetic field and induced electric field on conductive tissue can be calculated using Maxwell’s
equations as shown below. We utilize the software known as Sim4Life by Zurich MedTech, which
incorporates Maxwell’s equations into a Finite Element Analysis package and calculates E-fields
induced in biological tissue by time-varying B-fields.
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∇ ·E = ρ
ε0
(2)
∇ ·B = 0 (3)
∇×E = −∂B
∂t
(4)
∇×B = µ0 +(J+ ε0∂E∂t ) (5)
where E and B are the electric and magnetic field vectors, respectively, J is the is the current
density vector, ρ is the charge density, and ε0 and µ0 are the vacuum permittivity and permeability
respectively.
Furthermore, the temperature effect of electric and magnetic fields on biological tissue can be
found using the well-established Pennes Bio-heat Equation shown below.
ρc
dT
dt
= k(
∂2T
∂r2
ω
r
∂T
∂r
)+qm +ρbωbcb(Tb,a−T ) (6)
where T is the local tissue temperature, qm is the metabolic heat source term per unit volume, ω
is the perfusion rate, ρb is the blood density, cb is the specific heat capacity of the blood, Tb is the
blood temperature, and k is the thermal conductivity.
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4.11 Knowledge Gaps
Experts in non-invasive brain stimulation agree that the “holy grail” of the field is targeted stim-
ulation of deep regions in the brain while avoiding excess stimulation of cortical regions, which
may cause unintended and potentially harmful side effects. To this end, ongoing studies observe
B-fields induced by coils of various shapes, frequencies, and current amplitudes.[21] [97] [98] [99]
[100] [101] [102] However, it is common knowledge that a plethora of pathways naturally exist in
the brain, traveling from the cortex to deep regions. We posit that with the use of accurate models,
we can begin to show exactly how these pathways can be used for non-invasive deep brain stimula-
tion. Furthermore, we argue that by using detailed models of certain pathways, it may be possible
to explore a variety of stimulation techniques in the computational realm as a first step towards ani-
mal studies and human trials for new TMS-driven deep brain stimulation modalities. In this thesis,
we offer a novel motor pathway model for use in motor disorders such as Parkinson’s disease. Fur-
thermore, we consider the use of segmented fiber tract data for study of signal propagation during
TMS. We argue that this model may allow researchers to simulate specific deep brain regions stim-
ulated when TMS is performed on any area of the cortex. We believe that the combination of this
novel neuron network model and the segmented fiber tract model will be of significant benefit to
researchers who wish to explore the possibility of non-invasive brain stimulation methods to treat
patients with various neurological disorders.
Additionally, studies of combination DBS/TMS therapies are currently contradictory, as they are
based on a variety of scenarios and parameters. We show that for a particular scenario, wherein
PD patients have received medially-placed DBS leads, rTMS at the mouth motor cortex, to relieve
speech and swallowing symptoms, will not cause over-stimulation.
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.Modeling Approach
In order to perform macroscopic field profile analysis, we need 3D models used in conjunction
with Finite Element Analysis software. Here we use the FEA software Sim4Life, which has been
developed by Zurich MedTech specifically to explore field profiles within biological tissue.
5.1 Sim4Life Low-frequency Theory
Maxwell’s equations in the time domain were described in Eq. 2 - 5. These can be converted to
the frequency domain with assumption of harmonic oscillation e jωt .
X(r, t) = R(e jωtX(r)) (7)
∂
∂t
= jω (8)
where X is a complex vector.
Then,
∇×E=− jωB (9)
∇×H= jωD+J (10)
∇ ·D= ρ (11)
∇ ·B= 0 (12)
(13)
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where E is the E-field, D is displacement current, B is magnetic flux, H is magnetic field, and J is
the current density field.
We also have the following constitutive laws for linear materials:
D= εE (14)
ε= ε0εr (15)
B= µH (16)
µ = µ0µr (17)
J= σE+ j0 (18)
(19)
where ε0 is the electric permittivity of free space, εr is the electric permittivity of the material, µ0
is the magnetic permeability of free space, and µr is the magnetic permeability of the material. σ
is the ohmic loss, and j0 is the source current.
5.1.1 Decoupling Magnetic and Electric Fields
Here, decoupling the magnetic field from the electric field is important using the vector potential
A.
∇×A= B (20)
E=− jωA−∇φ (21)
(22)
And we separate these terms as follows:
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Es =− jωA (23)
Ei =−∇φ (24)
(25)
where φ is a scalar potential. Then we know that
E= Es +Ei (26)
For a solenoid,
∇ ·Es =− jω∇ ·A= 0 (27)
And for irrotation,
∇×Ei =−∇×∇φ= 0 (28)
Then, we can write:
∇× 1
µ
∇×A= ω2ε˜A− jωε˜∇φ+ j0 (29)
where ε˜ is the complex permittivity and can be defined by:
ε˜= εrε0 +
σ
jω
(30)
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5.1.2 Quasi-Static Approximation
A time-varying simulation considering Maxwell’s equations would be far too computationally in-
tensive to perform effectively. Therefore, we use a quasi-static approximation which transforms
the time-varying equations to the frequency domain.
The scaling property:
∇ · ε˜∇φ= O
(
ε˜φ
l2φ
)
(31)
∇ ·ωε˜A= O
(
ωε˜A
lA
)
(32)
where O is the symbol for ‘on the order of’. l2φ and lA are grid lengths. O(1/l) is the scaling
derivative. For scaling of φ-magnitude, we have
φ= O
(
ωAl2
lA
)
(33)
For Ampere’s law:
∇× 1
µ
∇×A= O
(
A
µl2A
)
(34)
ω2ε˜A= O
(
ω2ε˜A
)
(35)
jωε˜∇φ= O
(
ωε˜φ
lφ
)
= O
(
ω2ε˜Alφ
lA
)
(36)
(37)
Then,
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ω2ε˜A
∇× 1µ∇×A
= O
(
ω2ε˜µl2A
)
= O
((
lA
λ
)2)
(38)
jωε˜∇φ
∇× 1µ∇×A
= O
(
ω2ε˜µlAlφ
)
= O
(
lAlφ
λ2
)
(39)
where
ω2ε˜µ = k2 (40)
k =
2pi
λ
(41)
where k is the wave number and λ is the wavelength. Then according to Ampere’s law:
∣∣∣∣∣ω2ε˜µd2
∣∣∣∣∣<< 1 (42)
(
d
λ
)2
<< 1 (43)
Which, if d becomes large enough to equal the size of the grid, can also be written as
ω2εµd2 << 1 (44)
ωσµd2 << 1 (45)
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In this case, Ampere’s law becomes
∇× 1
µ
∇×A= j0 (46)
The vector potential A is the magneto-static vector potential A0. In this case, it is decoupled from
E, the electric field. Next, say that magnetic permeability µ is equal to the magnetic permeability
of free space µ0, and is constant over the entire domain. Then, using the Biot-Savart law,
A0(r) =
µ0
4pi
∫
Ω
j0(r′)∣∣r− r′∣∣d3r′ (47)
where Ω is the computational domain.
It is imporatant to note that we do not have direct control over the software’s handling of these equa-
tions, as they are hard-coded into Sim4Life. These equations and more can be found in Sim4Life
user documentation.
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5.2 Tissue Modeling
We use MRI data of real patients to create 3D head and brain models. Using the software Freesurfer,
along with high-resolution T1 and T2 weighted images, we can create high-resolution anatomically
accurate models with differentiated skin, bones, cerebrospinal fluid, grey matter, white matter, and
ventricles within the brain. The software inputs slices from MRI data such as the images shown in
Figure 18.
Figure 18: MRI data showing image slices. [17]
The Freesurfer software is open-source and developed for analyzing MRI images for develop-
ment of 3D models. The software inputs all MRI slices and uses contrast information to estimate
anatomical boundaries, such as that between the skin and skull, or between grey matter and white
matter. A 3D mesh is then created using these estimated boundaries and other geometrical infor-
mation taken directly from the input MRI data. Figure 19 shows one example of a model created
using Freesurfer.
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Figure 19: Image of 3D brain model cortex created using Freesurfer. [18]
It is important to note that by using Freesurfer, we are able to develop heterogeneous, anatomically-
accurate brain models for use with FEA simulation software. Because we are able to not only
acquire the geometrical complexities, but also assign different property values to each anatomy, we
have the ability to perform simulations with much higher accuracy than previously-used spherical
ball models.
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5.3 Head Models
We use head models developed in our lab by Hamza Magsood, as well as those developed at Iowa
State University by Erik Lee.[103] These models are created by downloading MRI data from the
Human Connectome Project, which compiled MRI images from thousands of patients, including
healthy people and those with neurological conditions. This MRI data is run through Freesurfer, as
described in the previous section, and 3D head models are output. One of these models, imported
into Sim4Life, is shown in detail below.
Figure 20: Image of 3D brain model developed using FreeSurfer. Note that all anatomies are
shown here: skin, skull, cerebellum, grey matter, white matter, and cerebellum.
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These anatomies can be imported separately as individual models and given different properties in
the simulation domain. See separate models of all anatomies below.
Figure 21: Skull (left) and cerebrospinal fluid (right) (CSF) of healthy model developed by us.
Figure 22: Grey matter (GM) (left) and white matter (WM) (right) of healthy model developed by
us.
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Figure 23 shows the ventricles and cerebellum in our head model.
Figure 23: Ventricles (left) and Cerebellum (right) of healthy model developed by us.
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5.4 TMS Coil Model
The standard TMS Coil has gone through some development over the years. The original coil was
a simple loop of coil as shown in Figure 24
Figure 24: TMS single coil from Magstim. [19]
Eventually, the double-coil system was introduced, and subsequently has been referred to as the
figure-of-8 coil, as shown in Figure 25.
Figure 25: Figure-of-8 coil from Magstim. [20]
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It was found that it is possible to induce a stronger, more focused electric field by using opposing
currents in the figure-of-8 coil than by using the single loop coil.[93] Note that it is easier to create
a higher-intensity electric field at a focused region with the figure-of-8 coil than with the single-
loop coil. For brain stimulation purposes, this coil is much more effective at targeting a specific
cortical area. Therefore, this coil has been FDA-approved for use during treatment of Depression.
Further developments in TMS research have led to multiple coil designs, with varying field effects.
Figure 26 shows 50 coil designs from Deng et. al, and Figure 27 shows corresponding calculated
electric field intensities.[21]
Figure 26: 50 coil designs from Deng et. al. [21]
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Figure 27: Field profiles of 50 coil designs from Deng et. al. [21]
Additionally, some groups have developed new, focal coils which stimulate smaller cortical regions
with higher intensity.[100]
However, in this work we model only the FDA-approved figure-of-8 coil. In this case, the current
in both coils must have equal equal amplitude but opposite flow directions, such that the magnetic
field in between the two coils adds up to a higher value than at any other point in the coil.
We model the figure-of-8 coil by creating 2 coils comprised of 9 concentric circular loops and
placing them next to each other, 5 mm away from the head model’s skull, to account for distance
created by the plastic insulation in a real-life clinical scenario.
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Figure 28 shows our model of the figure-of-8 coil placed next to a head model in the FEA software
Sim4Life.
Figure 28: Image showing Figure-of-8 coil placed beside our head model in Sim4Life.
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5.5 Duke Model
Zurich MedTech, the company which developed the Finite Element Analysis software Sim4Life,
has also developed a number of highly heterogeneous anatomically-accurate full-body models.
Here we show the full-body model Duke, which was created using MRI images of a healthy 34-
year-old male. The models created by Zurich MedTech are in some ways more detailed in their
anatomical accuracy, but we are unable to emulate their procedures as their methods are propri-
etary.
Not only is the Duke body more anatomically meaningful, but Duke’s brain tissue is also more
refined, and includes many small nuclei that we are unable to include in our own 3D models.
These additional nuclei may be added by hand, but the proprietary methods by which the company
creates these are unknown.
The additional small brain nuclei in Duke model include: Commissura anterior, commissura poste-
rior, Corpus Callosum, Hippocampus, Hypophysis, Hypothalamus, Medulla Oblongata, Midbrain,
Pons, and Thalamus. In addition to these, the Duke model contains the skin, bones, blood ves-
sels, fat, larger brain tissue models (grey matter, white matter, and cerebellum), nerves, muscles,
and much more. Because of these additional anatomies, the Duke model is a much more accurate
representation of the body’s reaction to TMS magnetic fields.
However, we have noted that the Duke model’s calculated field profiles often contain single-pixel
discontinuities in the deep brain and cortical regions, which may be due to issues importing the
highly complex mesh. Nevertheless, the anatomical details of the Duke model are shown in Figure
29. Figures 30 and 31 show various brain anatomies.
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Figure 29: Full-body Duke model developed by Zurich MedTech. This model is complete with
full skeleton, nerves, muscles, body fat, organs, and many more complex anatomical details.
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Figure 30: Cerebrospinal Fluid and Dura Mater in the Duke model.
Figure 31: Grey matter and white matter in the Duke model.
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Figure 32 shows the additionally segmented nuclei and brain structures added in the Duke model
that we were unable to segment into the models we developed. These include the commissura ante-
rior, commissura posterior, Corpus Callosum, Hippocampus, Hypophysis, Hypothalamus, Medulla
Oblongata, Midbrain, Pons, and Thalamus.
Figure 32: Extra anatomical structures segmented into Duke model.
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5.6 Tissue Simulation: Finite Element Analysis
The Sim4Life software uses Maxwell’s equations to calculate B-fields created by AC currents and
corresponding induced E-fields on biological tissue. Human models, created using MRI data of
real patients, can be imported once segmented using 3rd-party software. In this project we use
both models licensed by Zurich MedTech as well as models we have created in our lab using MRI
data downloaded from the Human Connectome Project. Members of the group, including Hamzah
Magsood, Gabrielle Jones, and Youssif Alkheder have been successful in segmenting models of
healthy patients as well as those with Parkinson’s disease. The following images show Sim4Life
simulations using our novel models.
Figure 33: Grey matter (left) shown clearly with TMS coils, and induced E-field on gray matter
surface (right).
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5.7 Simulation Steps and Parameters
For a TMS simulation in Sim4Life, there are a series of steps that must be followed to ensure accu-
rate simulation results. The following section gives information on how we conducted simulations
and extracted results for analysis.
5.7.1 Modeling
Within the Model tab in Sim4Life, we first imported the head model and the Figure-of-8 coil
previously created in Sim4Life as mentioned in the above section. Figure 34 shows the Model tab
in Sim4Life.
Figure 34: Model tab in Sim4Life with head model and Figure-of-8 coil imported.
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5.7.2 Simulation
In the Simulation tab, we first choose the type of simulation needed, the Magneto-Quasistatic
Simulation. Once it is chosen, the simulation parameters are populated. We specify material
parameters and grid details. In the first step shown in Figure 35, we use the Setup section to set the
simulation frequency to 2500 Hz to mimic the clinical coil current frequency of 2500 Hz.
Figure 35: Simulation tab in Sim4Life showing frequency in the Setup section.
Because the simulation is Quasi-Static, we can choose the current frequency of 2500 Hz, but
we cannot create a realistic scenario in which the patient is receiving 10 pulses/sec. Instead, the
software effectively takes a snapshot of the induced currents and electric fields induced at a point
at which the current is flowing through the coils at 2500 Hz.
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Next, we add all model materials into individual folders in the Material Settings section, as shown
in Figure 36. It is important to note here that Sim4Life has intrinsic properties available for bio-
logical tissue. After importing our homegrown models, we use these material properties by simply
assigning the property to its respective material model. Each part of the model must be dragged
from the Model Tree into its corresponding folder in the Explorer tab. Table 1 below shows the
various properties used by Sim4Life.
Figure 36: Simulation tab in Sim4Life showing models imported into Materials section.
Table 1: Material properties used in Sim4Life simulations.
Structure Mass Density (kg/m3) Electric Conductivity (S/m) Relative Permittivity
Skin 1109 0.17 1
Skull 1908 0.32 1
CSF/Ventricles 1007 1.7765 1
Grey Matter 1044.5 0.239149 1
White Matter 1041 0.26507 1
Cerebellum 1045 0.659667 1
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In addition to material properties, the software requires a current source, of which we create two.
After dragging each coil to its individual source setting, we use a current value of 5000 A for one
coil and -5000 A for the other. In this way, the current flow creates a Figure-of-8 path. This step
can be seen in Figure 37.
Figure 37: Simulation tab in Sim4Life showing coil settings.
Any line, spline, circle, or helix created in the Model tab in Sim4Life can be used as a current
source. However, note that a 3-dimensional material, either imported into the software or created
in the Model tab, cannot be used as a current source. Similarly, a line, spline, circle, or helix used
as a current source cannot be dragged into any material folder. If it is necessary to use a model
as both a material and as a current source, the software will require two models: one to be added
into a material folder, and the other (line, curve, circle, or helix) must be a 2d model used only as
a current source.
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5.7.3 Analysis
There are several methods of field profile analysis in Sim4Life. However, first it is important
to note that while the software calculate electric fields as 3-dimensional vectors, with individual
values for each axis, the E-field viewer shows the root-mean square (RMS) values for E-field.
Therefore, while we can visualize TMS-induced E-fields quite easily, in-depth analysis requires
extraction of raw data and independent analyses. These will be discussed in the next section.
Within Sim4Life, we require the use of two viewers: the Slice Viewer and the Surface Viewer.
Figure 38 shows a head model in the analysis tab after TMS simulation. The slice viewer is clearly
seen, along with a scale, units of which are in V/m.
Figure 38: Analysis tab in Sim4Life showing slice viewer.
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This can be created by selecting the simulation in the Explorer window, then selecting ”Overall
Field” in the Output View. A ”Sensor Extract” button will appear in the top bar. Clicking this
button will result in a population of various fields in the Output View. For the most part, we are
interested in the E-field. Therefore, we can select E-field and choose the Viewers button which
appears in the top bar. From Viewers, we select Slice Viewer.
In Figure 38, however, we have filtered out unnecessary field profiles from the background, skin,
skull, and other anatomies. To do this, we select E-field in the Output View and then click Field
Data Tools in the top bar. We select Mask Filter, and in the newly-populated Properties toolbar, we
simply select the anatomies to include in the filter and click Refresh.
We can also observe the E-field on the surface of any geometry. For purposes of certain analyses,
we extract E-field values induced on the surface of the gray matter. Figure 39 shows the E-field
surface viewer on the gray matter.
Figure 39: Analysis tab in Sim4Life showing surface viewer for gray matter.
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Other surfaces, such as the skin, skull, or white matter, can also be analyzed similarly. To do this,
we simply select Overall Field in Explorer, select EM E in the Output View, and drag the anatomy
from the Multi-Tree into onto the Overall Field option in Explorer. Several Interpolators are then
populated In Explorer. We select the bottom EM E(x,y,z,f0) Interpolator, and in the top bar click
Viewers, Surface Viewer.
In both Slice Viewer and Surface Viewer, the default view is on a dB scale. To convert to a linear
(log) scale, we simply click the small plot shown on the bottom left corner of the scale. It is also
possible to change the scale by double-clicking on it and changing its properties in the window
that pops up.
While it can be helpful to view the slice and surface viewers and find the maximum E-field on
Sim4Life’s User Interface, it is often more effective to extract the raw data for analysis. Here, we
show how we extracted data for Matlab analysis for brain volume and surface.
To extract volume stimulation data, we use the Slice Viewer with Mask Filter enabled, with grey
matter and white matter selected for filtering. In Explorer, we right-click on EM E(x,y,z,f0) -
Mask Filter, select Imp/Export on the popup window, and click MATLAB (R) Exporter. Then in
Explorer, we select MATLAB (R) Exporter and in the Properties window choose a file path and
click Refresh to save the Matlab data. These steps are shown in Figure 40.
We also use surface stimulation data to calculate focality or specificity of the stimulation. We
define these terms to mean the surface stimulated divided by volume stimulated. This calculation
is often helpful in determining how deep the stimulation goes in relation to how much of the brain
surface must be targeted. To extract surface stimulation data, we follow similar steps as volume
stimulation extraction. We bring up the surface viewer, and right-click on the bottommost EM
E(x,y,z,f0) - Interpolator, select Imp/Export option in the pop-up window, and click MATLAB (R)
Exporter. In the same way as for volume extraction, we choose a file path in the newly-populated
Properties window and click Refresh to save the data file. These steps are shown in Figure 41
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Figure 40: Analysis tab in Sim4Life showing extraction of volume stimulation data.
Figure 41: Analysis tab in Sim4Life showing extraction of surface stimulation data.
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.Results/Completed Projects
6.1 Effect of Anatomical Variation in TMS Response
The first project we undertook was based on the fact that each TMS patient requires an individ-
ualized approach to TMS treatment. The hypothesis was that this is likely due to differing brain
geometry and/or size, but more specifically, age-related efficacy has been observed in the past.
[104] We wanted to verify or deny this claim by performing simulations of TMS on models of var-
ious ages and calculating induced electric field. We obtained MRI data of adult patients between
the ages of 25 and 65, created 3D head models using Freesurfer and Simnibs, and imported these
models into Sim4Life for TMS simulations. Figure 42 shows the models that were used for this
study.
We simulated TMS with coils positioned directly above the models’ heads as shown in Figure
42. We used healthy and Parkinsonian models downloaded from PPMI database, as well as the
Duke and Ella models developed by the company by the company IT’IS, which creates models for
Zurich MedTech. Figure 43 shows analysis of these models.
We exported stimulation data and ran it through our Matlab programs (Attached in appendix) to
calculate brain volume and surface stimulated. These programs effectively find the fraction of the
brain volume/surface which has been stimulated above a certain threshold. In the past, stimulation
threshold has been a function of the maximum E-field induced in each individual model. [103]
However, because this maximum E-field is variable depending on the model, we introduce an
additional ”absolute threshold” which simply finds the fraction of the brain volume/surface above
a specified numerical value. Matlab code analyzing volume stimulated and surface stimulated can
be found in Appendix A and Appendix B, respectively.
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Figure 42: All head models used in this study. Top two rows show healthy models while bottom
two rows show PD models.
We started by finding the brain-scalp distance (BSD) for each model in order to find any correlation
between age and BSD. It has been suggested in the past that the lower efficacy in elderly patients
may be due to brain atrophy and subsequent larger BSD as age increases. Higher BSD increases
the distance between the TMS coils and cortical surface. However, the following plot in Figure
44, which shows our models’ ages and BSD, shows that there is not necessarily any correlation
between age and BSD. Healthy patient MRI data is downloaded from the Human Connectome
Project (HCP), and Parkinson’s patient MRI data is downloaded from the Parkinson’s Progression
Markers Initiative (PPMI).
We believe that the lack of correlation between age and BSD is due to the fact that we are observing
data across a population. While it is true that for individuals, BSD likely increases over time as
the brain atrophies, there is not necessarily a decrease in brain volume across a population. In
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Figure 43: Surface viewers (top row) and slice viewers (bottom row) in Analysis tab of Sim4Life
showing induced E-field in healthy, PD, and Ella model.
other words, while a patient’s brain does atrophy as they age, it may still have a larger volume than
another younger individual’s brain. This variation is most likely caused by differences in genetics,
environment, and lifestyle.
Because we do not observe a correlation between age and BSD, we base the rest of our data not
on age but on BSD. After performing simulations, we plot the stimulation analyses against BSD.
As in previous literature, we use a stimulation threshold of Emax2 such that if a cell’s E-field value is
calculated to be equal to or greater than half of that particular model’s maximum induced E-field,
we consider that cell to be stimulated. However, because each individual patient’s Emax is different,
it is difficult to find any correlation between BSD and Volume Stimulated. This plot is shown in
Figure 45 below.
Similarly, we do not necessarily see any correlation between Brain-Scalp Distance and Surface
Stimulated in Figure 46.
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Figure 44: Age vs. Brain-Scalp distance in our models. No clear correlation is present.
Figure 45: BSD vs. Volume Stimulated for each model.
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Figure 46: BSD vs. Surface Stimulated for each model.
However, if we use a particular numerical value to designate stimulation, we can observe a clear
trend between BSD and Volume and Surface Stimulated, as seen in Figures 47 and 48. Note also
that while the healthy patient data we downloaded was that of younger patients, and the older
patient data was that of Parkinson’s patients, there is no clear correlation between PD and BSD or,
in the case of Figures 47 and 48, between PD and TMS stimulation.
We also observed the maximum E-field induced in each patient and compared against the brain-
scalp distance. There seems to be some correlation, as seen in Figure 49.
Finally, we calculate “stimulation specificity” or the ratio of volume to surface stimulated, by
taking the number of volume stimulated fraction of each model and dividing by surface stimulated
fraction. Once again, it is difficult to observe any clear correlation when using individualized
stimulation parameters. This can be seen in Figure 50. However, we also observed the correlation
between specificity and maximum induced E-field in each model, and find an interesting trend, as
seen in Figure 51. It is clear that as Emax increased, the specificity of stimulation increases as well.
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Figure 47: BSD vs. Absolute Volume Stimulated for each model.
Interestingly, there seems to be a higher variation between the older, Parkinson’s models than with
the younger healthy models.
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Figure 48: BSD vs. Absolute Surface Stimulated for each model.
Figure 49: BSD vs. maximum induced E-field.
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Figure 50: Stimulation specificity, defined as Volume Stimulated/Surface Stimulated.
Figure 51: Stimulation specificity vs. maximum induced E-field. A clear trend is visible.
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We can conclude from this work not only the more obvious result, that in our models, age is not
necessarily correlated to brain stimulation, but also that the somewhat common notion among TMS
clinicians, that older patients generally require higher stimulation thresholds, may not hold true.
We posit that it is more beneficial for the patient’s health to find the brain-scalp distance using the
individual’s MRI data, and set stimulation thresholds accordingly. It is clear from our data that
many elderly patients retain the same high brain volume, and subsequently, low BSD, as many
younger patients. Therefore, stimulation at unnecessarily high thresholds may cause negative side
effects such as seizures in elderly patients.
Similarly, it is clear that many younger patients may have surprisingly high BSD and low brain
volume, and so lower stimulation thresholds generally used for younger patients may not have the
required efficacy needed for treatment. Therefore, we argue that it is crucial for TMS clinicians
to understand individual patients’ brain volume and brain-scalp distance to provide effective TMS
treatment.
See attached publication on our study of the effects of anatomical variability on TMS treatment.
[105] Results showed that although brain atrophy for individuals is well-studied, brain-scalp dis-
tance (BSD), and thus motor threshold (MT), cannot be predicted by age alone. Furthermore, while
induced E-field is a function of BSD, there is no direct correlation between induced E-field and
patient age.
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6.2 Combination of DBS and TMS for Parkinson’s disease
6.2.1 Phase I: Direct Magnetic Field Effects
Based on discussions with Dr. Kathryn Holloway from the Neurosurgery Department of Virginia
Commonwealth University Health Systems, we were were interested in exploring the implications
of combining TMS with Deep Brain Stimulation (DBS). Parkinson’s Disease patients often exhibit
motor symptoms such as hypophonia and dysphagia, even after receiving DBS. [72] [83] [84]
Unfortunately, DBS has been unable to address these symptoms, and we argue that they may be
improved by stimulating the cortical region of the brain which is responsible for motor-related
tasks (M1 or Motor Cortex). TMS is easily able to stimulate areas of the cortex. However, it is
possible that time-varying magnetic fields from TMS may induce eddy currents on the surface of
the conductive parts of the DBS leads. While the issue of combining DBS with TMS has been
addressed by a few studies in the past, we argue that the head models used in these studies were
not sufficiently complex to find accurate induced electric and magnetic fields.[106] [107]
For this project, we calculated induced electric and magnetic fields in the deep brain region in the
presence of conductors and a long cylindrical body, which was composed of a conductive wire
wrapped in an insulating sleeve. We used Sim4Life v3, which was the most up-to-date version of
the software at the time, with the complex, heterogeneous Duke model developed by IT’IS. At this
time, we were unable to develop a highly complex and accurate DBS lead model, so we focused
primarily on calculating induced E-field in the deep brain region due to the presence of conductors
in the area and TMS coils at the motor cortex.
Simulation technique for these simulations differentiated from the regular simulations done for
previous work. Due to the presence of the conductors, we first performed a Static Vector Potential
simulation as a first step, to calculate the induced E-field on the conductors. Then, using results
from the Static Vector Potential simulation as the source input for the Magneto Quasi-Static Vector
Potential simulation, we found the induced E-field on the biological tissue. Finally, because we
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were interested in studying potential temperature increase in the brain tissue, we used results from
the Magneto Quasi-Static simulation as source input for a Transient Thermal simulation.
The first deviation from a traditional Sim4Life simulation was in the Modeling tab. As usual, we
import our biological model, in this case the Duke model, as well as our Figure-of-8 Coil. We
also create a simple DBS lead model, with 4 conductors and a long lead body comprised of a
conductive wire (cylinder) and insulating sleeve (hollow cylinder surrounding the wire model).
This simple lead model can be seen in Figure 52. Note that due to some instabilities in this older
version of Sim4Life, we were unable to position the conductors close enough together to resemble
an accurate DBS lead.
Figure 52: Simple DBS lead model with four conductors and long lead body with wire and sur-
rounding insulating sleeve.
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Next, to perform the Static Vector Potential calculation correctly, the Duke model and lead model
needed to be encompassed in a “Wire Block”. In the Model tab, we simply clicked on the Duke
model in Explorer, and in the top bar select Extract, Wire Block. This gives us a large wire frame
in which the whole Duke model is encompassed, as shown in Figure 53.
Figure 53: Duke model encompassed in Wire Block in the Model tab.
67
Next, we switched to the Simulation tab and created a new Static Vector Potential Simulation.
We used frequency 2500 Hz, and in the Materials section added the Duke model with all separate
anatomies populated automatically with their properties. To add the DBS lead model, we created
two different material settings – Insulators (modeled as PVDF) and Conductors (modeled as Plat-
inum). All conductive parts of the lead, including the conductors and wire, were placed into this
material folder and set as a PEC, or Perfect Electrical Conductor. This ensured that the materials
were modeled as metallic and not dielectric. The insulating sleeve was placed into the Insulators
materials folder and and the settings were as follows: Dielectric, Mass Density 1780 kg/m3, and
Conductivity 0.2 S/m. The Figure-of-8 coil was used as the current source as usual. All other
simulation settings were set similarly to the regular Magneto Quasi-Static simulation.
After the Static Vector Potential simulation was complete we created a new Magneto Quasi-Static
simulation. All settings were set as usual, with the exception of the Source folder, for which we
created a new Vector Potential Source folder. To use the previous simulation’s results as the input,
we dragged the Vector Potential simulation’s Sensors folder into the newly-created Vector Potential
Source folder. All other settings were set as usual and the simulation was performed.
We performed these simulations for a range of TMS coil currents in order to ascertain the dif-
ferences between induced E-field in the deep brain regions from varying the TMS intensity. We
used TMS coil current of 1000 A, 3000 A, and 5000 A. After performing the simulations, we
found maximum induced E-field in the area of the cortex closest to TMS coils and DBS conduc-
tors. These induced E-fields are shown in Figure 54. It is clear that induced E-field at the site of
electrodes is much lower than at the cortex, and far too low to cause neuron stimulation.
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Figure 54: Maximum electric field induced on the cortex and at the site of DBS conductors in the
deep brain region.
Finally, we were interested in analyzing the temperature variation in the brain tissue as a result of
the combination treatments. For this, we created a new Thermal Transient simulation. The settings
for this simulation are described below.
Setup: Pennes
Time: 10,000 sec
Time Step Factor: 1 sec
The Materials section was populated as described above, but the thermal simulation requires ther-
mal properties to be specified for each material. The Duke model’s properties were automatically
supplied, and the material properties we used for the DBS lead are described in the following
tables.
Heat generation properties were constant for all materials:
Type: Constant
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Table 2: Basic thermal properties used for DBS lead materials.
Material Mass Density ( kgm3 ) Specific Heat Capacity (
J
kgK ) Thermal Conductivity (
W
mK )
Electrodes (Platinum) 21450 133 72
Insulators (PVDF) 1780 1200 0.2
Heat Generation Rate: 0 Wkg
Heat Generation Interval: Whole Simulation Time
The following table gives heat transfer properties for each DBS lead material, calculated using the
material property and geometry of the particular material.
Table 3: Heat transfer properties used for DBS lead materials.
Material Type Heat Transfer Rate ( Wm2K ) Convective Temperature (K)
Electrodes (Platinum) Constant 3.97487E6 37
Wire (Platinum) Constant 453828 37
Wire Insulation (PVDF) Constant 1048.45 37
Small Insulators (PVDF) Constant 11041.3 37
Long Insulators (PVDF) Constant 488.858 37
Initial conditions were set as follows:
Initialization: Fixed Value
Overall Temp: 25 ◦ C
A new Initial Conditions settings folder was created, in which Duke was placed. For this new
folder, the Overall Temp was set at 37 ◦ C.
The Source was input from the Sensors folder of the completed Magneto Quasi-Static simulation.
Frequency: 2500 Hz
Interpolation: Energy Preserving
Interval Mode: User Defined Interval
Start Time: 5000 sec
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Stop Time: 6000 sec
Boundary Conditions: Mixed
Outside Temp: 25 ◦ C
Heat Transfer Coefficient: 5 Wm2K
Heat Flux: 0 Wm2K
Sensors: Whole Simulation Time
Max. No. Samples: 100
Figure 55 shows the temperature variation in the TMS-targeted cortex as well as the DBS contacts
in the deep brain region. Note that temperature does not increase more than 0.5 ◦ C in any region
of the brain.
Figure 55: Temperature variation for all simulations in cortex (solid) and DBS contacts (dashed).
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See attached publication on the first phase of combination of TMS and deep brain stimulation
(DBS) for treatment of mouth/throat symptoms in PD patients. [108] A highly simplified DBS
lead model was created for use in this project, and only the effects of direct induced E-field on the
lead conductors was observed. We found that there was insufficient E-field, induced from direct
applied B-field, in the deep brain region to induce stimulation from a combination of TMS and
DBS. Furthermore, there is a negligible temperature increase (¡0.5 ◦C) in both the cortex and deep
brain region.
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6.2.2 Phase II: Effects of Induced Current
Next, we were interested in studying the effects of any TMS-induced current in the top of the DBS
lead which would propagate down to the contacts and thus cause stimulation in the deep brain
region. To answer this question, it was necessary to develop a new, accurate, complex DBS lead
model, which was not possible in the simple geometries of Sim4Life. Therefore, an undergraduate
student in our lab, Ciro Alcoba Serrate, used SolidWorks to develop a highly-accurate and complex
DBS lead model.
Furthermore, it is important to include extra wiring that coils around the patient’s skull, as there
may be current induced in these parts of the wire from cortical TMS. An example of this type
of DBS coil winding is shown in Figure 56 below. To create accurate geometry, we followed
MedTech literature for DBS lead 3387/3389, as shown in Figure 57
Figure 56: X-Ray image of patient with DBS lead. Notice extra wiring coiling around patient’s
skull. [22]
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Figure 57: Image of DBS lead 3387/3389 schematic from Medtronic literature. [23]
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The introduction of DBS wiring, particularly that which is winding around the patient’s skull, will
be crucial in determining any current which may be induced by TMS and travel down to the lead
contacts in the deep brain region. Importantly, this consideration adds a new dimension to this
project; in the previous publication, we were only accounting for induced E-field caused in the
deep brain region by any magnetic fields which may have propagated to that region. With the new
complex DBS lead, we are able to calculate any current induced in the DBS wires close to the
TMS coils. Additionally, we will consider the possibility of TMS-induced current in the proximal
contacts which are placed near the back/side of the head to connect the lead wire to the battery
pack or IPG. Because these contacts are conductive, it is important to place the TMS coil close to
these proximal contacts to calculate potential currents induced at that location. Figure 58 shows
our new, complex, highly accurate DBS model developed in SolidWorks, complete with full lead
body, wire, wire insulation, and proximal and distal contacts. We were able to import this model
into Sim4Life to perform simulations. Figure 59 shows details of the imported DBS lead model in
Sim4Life.
Note that this model includes detailed wiring, with 4 separate wires coiling around each other to
end at one conductor each, as is the case with real DBS leads. This is important to note because
although each wire terminates at an individual contact, the 4 wires coil together throughout most
of the lead body, and each wire has the potential to carry any TMS-induced current to its respective
lead, thus stimulating the deep brain nuclei it targets. This particular detail can be seen in Figure
60.
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Figure 58: New complex DBS lead model developed in SolidWorks.
Figure 59: Complex DBS lead model imported into Sim4Life.
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Figure 60: Wire details in our complex DBS lead model. Note the four individual wires, each
terminating at one contact.
In this project, we were interested in studying a specific scenario, as specified by our collaborator
Dr. Kathryn Holloway, in which patients who have received DBS leads, placed medially in the
head, also exhibit speech and swallowing symptoms. Stimulation of the inferior region of the M1,
or Motor Cortex is thought to improve these symptoms. Therefore, we placed our leads relatively
medially in each model’s head, although anatomical differences prevented the lead from fitting
perfectly in each model in the same location. Furthermore, we targeted the inferior-most part of
the M1 in an effort to stay true to the given scenario. Literature search shows that some studies
have been done in the past to address the possibility of combining TMS with DBS treatment. The
results, however, have been mixed, and we posit that this is due to significant variations in both
lead and head model accuracy, as well as location of DBS and TMS relative to the brain. Table 4
addresses these previous studies as well as our particular case.
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We attempted to calculate induced E-field at various regions in the brain, but the Sim4Life software
was unable to handle some of complexities of the DBS lead. One of the biggest issues we faced was
the creation of discontinuities at various points in the DBS lead model. We were able to recognize
these as discontinuities as they were single-pixel errors of extremely high E-field values at regions
of relatively low E-field, and the associated induced current was not on par with the high E-field
value at the same cell. For this reason, we continued with the paper with only induced current
rather than E-field. Figure 61 shows an example of induced E-field calculations using the complex
DBS lead.
Figure 61: Coronal view of a head model with complex DBS lead model inserted and simulated
TMS.
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We were first interested in studying the effect of different orientations with regards to the TMS
coils and DBS lead. Because we were looking for the worst-case scenario, it was important to find
the orientation which would lead to the highest induced current. We would then perform further
simulations on all other models using the highest-current orientation. Therefore, we performed
simulations using a variety of coil orientations near the M1 region, at the top of the head closest to
the DBS lead, and at the back of the head closest to the proximal conductive contacts which would
connect the wire to the battery pack or IPG. Additionally, for each of these setups we also rotated
the TMS coil by 90 degrees from its normal position, in order to account for the well-observed
phenomenon of angle-dependent E-field induction by TMS in the cortex. Figure 62 shows the
various orientations we used for the healthy model.
Figure 62: Various orientations tested in our simulations.
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It is important to note here that Sim4Life calculates current density rather than current. To calculate
current, we found the highest current density value induced in the DBS lead wires and multiplied
by the cross-section of the wire. Current density was in units of Am2 , so we multiplied this value
by pir2 where r = 0.05mm, for the radius of the DBS wires. Then, of the various orientations
and locations tested, we found that the highest induced current in the DBS leads was caused by
orientation (a). This is most likely due to the orientation and location of the magnetic field relative
to that of the four DBS wires in the lead body. The current values are plotted in Figure 63.
Figure 63: Current values induced in the DBS lead due to different TMS Coil orientations. Orien-
tation (a) clearly induces the highest amount of current.
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After finding that the highest induced current was caused by orientation (a), we positioned the
TMS coil similarly in all other models. We also inserted DBS leads in all these PD head models
as medially as the anatomy would allow. Note that it was crucial to position the DBS lead such
that no part of the lead was extending through the model’s skin; in such instances, the E-field and
induced current at these points jumped significantly in these cells, signaling a software glitch. For
this reason, it was necessary to trim the lead to exclude the proximal lead contacts in order to fit
the lead into each PD patient. Because the proximal leads did not cause higher induced current
than orientation (a), this decision did not effect the outcome of the study. Figure 64 shows all ten
PD models used in these simulations with inserted DBS leads.
Figure 64: Ten PD models with DBS leads inserted. Note the slight variance in anatomy for all
models.
Once we had placed the leads inside each model and positioned the TMS coil in orientation (a), we
performed the simulations and analyzed induced current values in the DBS leads. We found that
none of the models’ current values exceeded 2 µA, while normal DBS stimulation currents are on
the order of mA. This data is shown in Figure 65.
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Figure 65: Current induced in ten PD models and one healthy control model. Note that current
never exceeds 2 µA, which is orders of magnitude below that of DBS stimulation (mA).
Note that each patient, due to varying anatomy, has different stimulation requirements to reach
stimulation threshold. For example, patients with higher brain-scalp distance tend to require higher
stimulation current in order for their cortex to receive high enough B-field for stimulation. Sim-
ilarly, our models all require different TMS current in order to reach the stimulation threshold of
150 V/m on their cortex due to anatomical variations in each head model. We found these TMS
currents and stimulated each model at its respective current to ensure that each brain was receiving
stimulation.
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We also calculated the temperature variation in the control model for orientation A during and
after 30 minutes of TMS stimulation, which is typically the time it takes to perform clinical TMS.
We found the temperature in the cortex and DBS contact does not exceed 34.5 ◦ C, which is a
negligible increase. The variation can be seen in Figures 66 and 67.
Figure 66: Surface view of temperature variation in the cortex before, during, and after 30 minutes
of TMS. Note that temperature increase in all areas is negligible.
The following is the latest version of our publication of Phase II of the DBS project (in-progress),
in which we have studied propagation of TMS-induced current on any part of the lead. We find
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Figure 67: Plot of temperature variation on the cortex (solid line) as well as the deep brain region
(dashed line).
that for our particular clinical scenario of TMS in the mouth motor region while DBS leads are
placed medially in the head, there is some induced current in the DBS wires. However, this current
is orders of magnitude lower than normal DBS stimulation. Therefore, our simulations suggest
that for our scenario with DBS leads in the OFF state, the combination TMS/DBS treatment may
not cause over-stimulation of the deep brain regions.
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6.3 Spiking Neuron Network Model
6.3.1 Effect of Demyelination on Neuronal Response to TMS
In addition to studying the macroscopic tissue effects of TMS, we were interested in observing
TMS stimulation on a neuronal level. Neuron physiology is complex, and there are certainly stim-
ulation effects that we cannot observe by using Finite Element Analysis. Neuron modeling allows
for study of not only single neurons, but also entire neuron populations as well as networks, in
which populatinos of neurons are interconnected. To do this, we turned to neuron modeling us-
ing the Python package called NEST. While there are several neuron and neural network softwares
available today, NEST allows for observation of whole networks rather than focusing on individual
neuron physiology. Many neuron modeling softwares tend to focus on the effects of stimulation
of individual neurons rather than an entire system. Generally, neural network softwares are used
for machine-learning algorithm development, and so do not use accurate neuron physiology infor-
mation and do not allow for observation of actual neural signals. Furthermore, NEST is a package
of modules for the computational language Python, so we are not constrained by the rules of a
traditional software using Graphical User Interface (GUI) for user communication. It is possible to
write the program to perform using our specifications, and any modeling, simulation, and analysis
details can be added easily by simply writing the corresponding code in Python. Using NEST, we
can observe voltage and signal changes in single neurons as well as neuron populations. NEST
allows for modeling of several types of neurons, each with its own benefits and constraints. For
our simulations, we use the integrate-and-fire (iaf) neuron model, which integrates all incoming
signals and fires, or passes on the signal, once it reaches the threshold potential of -70 mV. Figure
68 shows the voltage change in a single neuron given a random (Poisson) input signal. Note that
the neuron starts at resting potential of -55 mV. We can not only deliver random noise to each
neuron, we can also specify its frequency and connection weight. Furthermore, we can create our
own stimulation generators, such as a TMS or DBS signal generator.
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Figure 68: Voltage variation in a single neuron given random noise input using NEST. Note that the
voltage drops back to resting potential (-70 mV) when then neuron fires after reaching threshold
potential (-55 mV).
Note that although in reality, the voltage of a firing neuron will often reach up to +40 mV, the
integrate-and-fire neuron in NEST simply comes back down to resting potential. Using entire
populations of these single neurons, we can observe larger system effects of stimulation. Here,
we were interested in the effects of TMS on abnormal neurons, specifically those that have been
demyelinated.
Myelin is a fatty layer which surrounds the axon of many different types of neurons and allows
for fast signal conductivity. Although myelin itself is an insulating substance, its presence on
the neural axon causes electrical signals to jump from node to node, rather than to travel down
the entire length of the long axon. In certain neurodegenerative diseases, however, neurons be-
gin to undergo destruction of the surrounding myelin. This is called demyelination, and leads to
slower conduction velocity across the neuron body, and thus may be a cause of some pathological
symptoms. Demyelination has been shown to occur in Multiple Sclerosis (MS), Guillain-Barre
Syndrome (GBS), and multiple other diseases. [113] [114] [115] The process of demyelination is
shown in Figure 69.
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Figure 69: Neuron with myelin wrapped around its axon. Note that the nodes, or the spaces
between the axonal segments, remain free of myelin. This allows the electrical signal to jump
from node to node, thus significantly increasing conduction velocity.
We were interested in the possibility of performing TMS on demyelinated cortical neurons, such as
those of a Multiple Sclerosis patient. To do this, it was first necessary to establish the stimulation
threshold in terms of TMS current. We created a TMS model in NEST by using an ac-generator
function with frequency of 2500 Hz and 10 pulses per second, following clinical parameters. Be-
cause the TMS model in NEST needed to be a current generator rather than a voltage generator,
it was necessary to find the current induced on the body of a cortical neuron during clinical TMS.
Neuron physiology can be quite variable depending on the type of neuron and the part of the brain,
so we used typical values of cortical neuron physiology, which we found in literature. The values
were: diameter 1 µm, axon length 10 mm, resistance 32 Ω. [116] [117] [67] Using these values,
we calculated corresponding necessary E-field by using the following formula:
E-field Value (
V
m
) =
IR
Area
=
Induced Current (A)×Resistance (Ω)
Axon Diameter (m)
(48)
Because the TMS stimulation threshold is typically assumed to be 150 V/m, we wanted to apply
the corresponding induced current to the neurons in the simulation. We were also interested in
finding the corresponding magnetic field induced on the surface of the TMS coil, which we did
by using the FEA software Sim4Life. Demyelination occurs not on the grey matter (soma), but
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the white matter (axon), so here we are only concerned with E-field induced on the white matter.
Figure 70 shows our results comparing E-field induced on cortical white matter, current induced
on neuron body, and B-field on the surface of TMS coils. Raw data for this plot can be found in
Appendix C and Appendix D.
Figure 70: Electric field induced on cortical brain tissue with corresponding calculated induced
current on the neuron body and magnetic field required on the TMS coil surface.
By iterating through the simulation with increasing TMS-induced current amplitude, we found that
NEST neurons react with significantly increased synaptic activity when stimulated with current of
40,000 pA. As can be seen in the above figure, this value is very close to the 150 V/m threshold,
and so we find our NEST neuron model and TMS generator validated.
Next, to simulate demyelination, we slowly increase the neurons’ capacitance, thus decreasing the
conduction velocity and modeling a decrease in myelin. In NEST, the iaf neuron’s default capaci-
tance is set at 250 pC. We increase this capacitance until we see an almost complete lack of signal-
ing in the population, at 290 pC, at which we assume complete demyelination. We use a population
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size of 1000 neurons and introduce a noisy background current. Then, we add TMS stimulation
current and increase this value to observe differences in neuron firing. Figure 71 shows the ob-
served firing rate for the neuron population of 1000 neurons, with varying capacitance values (de-
myelination) and TMS-induced current values. We found that relatively demyelinated neurons can
be stimulated with clinical TMS parameters, and that highly demyelinated neurons require higher
amounts of TMS current, which would likely be too high for FDA-approved treatment.Python
script for this project can be found in Appendix E.
Figure 71: Neuron firing (spikes/sec) in population of 1000 neurons, with varying levels of capac-
itance and TMS-induced current.
See attached publication on our project modeling the effect of TMS on neuron populations with
varying degrees of demyelination. [118]
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6.3.2 Signal Propagation of TMS in the Motor Pathway
Although we had studied the effects of TMS on DBS leads, it was unclear what the effects of TMS
may be on the actual deep brain nuclei with regards to signal propagation in the motor pathway
from the cortex to the basal ganglia. We were interested in a potential TMS treatment that may
help treat PD in a similar manner to DBS. To study these deep brain effects of Parkinson’s Disease,
DBS, and TMS, it was necessary to observe neuron firing in the motor circuitry. For this purpose,
we created a new neuron network model using NEST, complete with basal ganglia nuclei and
the network complexities present. The motor pathway has been well-studied and the structural
pathways and connections have been mapped by various groups. [24] [119] We used these models
to create a complex, connected circuit of nuclei in NEST. Each nucleus was created separately
using 800 neurons, which we found to give us the optimum balance of accuracy and computational
time. Each nucleus was given some random noise in a given range, based on in-vivo studies which
have observed background neuron firing in the basal ganglia. [24] [25] [26] [27] [28] [29] [30]
[31] [32] We use the following initialisms for the nuclei:
Cortex = CTX; Striatum = STR; Striatum D1 neurons = STRD1; Striatum D2 neurons = STRD2;
Substantia Nigra pars compacta = SNc; Globus Pallidus externus = GPe; Globus Pallidus internus
= GPi; Subthalamic Nucleus = STN.
Table 5 outlines experimentally-found neuron firing values that were used as guidelines for our
model’s signal output.
Table 5: Approximate firing rates found in experimental studies, which were used as known outputs
for our functional motor pathway model.[24] [25] [26] [27] [28] [29] [30] [31] [32]
Nucleus Healthy Firing (Hz) Parkinsonian Firing (Hz)
CTX 5 N/A
STR 1 10
SNc 2 N/A
GPe 70 60
STN 20 40
GPi 70 90
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All excitatory and inhibitory connections between nuclei were made, and connection weights were
specified based on known signal output data. We first created a healthy model and verified correct
output signals for all nuclei. We then modeled a Parkinsonian circuitry by severing the connection
between the SNc and Striatum, thus eliminating dopaminergic input from SNc to STRD1 and
STRD2. Figure 72 shows our structural model of the motor pathway, developed using the cited
literature, for both healthy and Parkinsonian/Dystonic circuitry. Notice that with the dopaminergic
input removed, signals decrease in the Striatal D1 neurons and they increase in the Striatal D2
neurons. These disturbances then cause further downstream effects, leading to well-established
increase in burstiness, or synchrony. It has been theorized that this synchrony is the cause for
motor symptoms in PD and Dystonia. [120] [121] We are therefore interested in studying methods
of decreasing the level of syncrhony in these nuclei.
Figure 72: Structural model of healthy motor pathway (left) and Parkinsonian pathway (right).
Blue lines correspond to excitatory connections while red lines correspond to inhibitory connec-
tions. Notice in the Parkinsonian pathway, the lack of dopaminergic input, thicker lines for increase
in signal propagation and thinner lines for decrease in signal propagation.
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Through trial-and-error, we were able to find the optimum background noise range for each nu-
cleus, as well as connection weights between the nuclei shown in Figure 72, such that the output
signals were accurate; when dopaminergic input was removed from the Striatum, the resulting neu-
ron firing rates were also true to experimentally-found firing rates in Parkinsonian basal ganglia
nuclei. Details of background noise and connection weights between noise generators and nuclei
are given in Table 6. Connection weights and delays between nuclei are given in Table 7.
Table 6: Poisson noise generator parameters for each nucleus.
Excitatory = 8300 - 8500 Hz; Inhibitory = 2000 - 2100 Hz
Nucleus Excitatory Conn. Inhibitory Conn.
Cortex 1.1 -1.28
Striatum (D1) 1.0 -1.1
Striatum (D2) 1.0 -0.85
SNc 1.0 -0.9
GPe 1.3 -0.5
STN 1.15 -0.9
GPi 1.1 -1.4
Table 7: Connection weights between nuclei and delays as found in literature. [24] [33]
Nuclei Connected Exc.(+) or Inh. (-) Weight Delay (ms)
CTX - STN + 1.0 5.9
CTX - STR + 0.1 5.1
SNc - STRD1 + 1.0 0.5
SNc - STRD2 - -5.0 0.5
STRD1 - GPi - -2.0 4.0
STRD2 - GPe - -5.0 5.0
GPe - STN - -0.3 4.0
STN - GPi + 1.2 1.5
STN - GPe + 1.0 2.0
Using these parameters, we were able to model healthy and Parkinsonian firing rates, which
matched those found in past experimental studies. Next, we modeled the signal from a DBS lead
and connected it directly to the GPi to model a PD patient receiving DBS to the GPi. DBS current
parameters were modeled with frequency 185 Hz, pulse width 0.09 ms, and current amplitude 0.1
mA. These DBS parameters matched those used by our collaborator, Dr. Kathryn Holloway in
clinical DBS treatment of PD patients.
Because we were also interested in studying downstream effects of TMS, we modeled TMS in this
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simulation similarly to that used in the demyelination project. TMS-induced current was modeled
with frequency of 2500 Hz, pulse frequency varying between 10 and 60 pulses/sec, pulse width
0.4 ms, and current amplitude 40,000 pA.
To quantify synchrony S, we use the following method. Assume that a nucleus is firing in complete
synchrony, with N neurons, either firing simultaneously or remaining silent. Assume that the
neurons fire at every other timestep. Then, given an array of timesteps and signals recorded during
those timesteps, we would see half the timesteps with signal count 0, and the other half with signal
count N. In this case, the mean µ = N/2, and the standard deviation σ = N/2. Maximum signal
frequency at any given point would be fmax = N and minimum signal frequency would be fmin = 0.
The range of the data is fmax− fmin. We can then classify synchrony as
S =
2σ
fmax− fmin (49)
For a neuron population with complete synchrony, we see
S =
2σ
fmax− fmin =
2(N/2)
N
= 1 (50)
As the nucleus becomes less and less synchronous, we begin to see the firing frequency approach
the mean, with about half of the neurons firing at any given timestep, and the standard deviation
begins to decrease. Then if σ approaches 0,
S =
2σ
fmax− fmin =
2(0)
fmax− fmin = 0 (51)
Therefore, we can say that with this method of synchrony quantification, a nucleus with complete
asynchrony gives S = 0, and one with complete synchrony gives S = 1. We measure these values in
our model; Table 8 gives firing data found for the GPi. It is clear from our measurements that the
healthy GPi has a low synchrony of S = 0.08. In the Parkinsonian state, this synchrony increases
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significantly to 0.52. This result serves to further validates our model, as the transition to highly
bursty firing in the basal ganglia is well-established in the field.[120] [121]
With the addition of DBS, both the firing rate and synchrony increase, with S = 0.62. In the past,
it was theorized that DBS causes a lesioning effect in the basal ganglia, thus minimizing firing in
the targeted nuclei. [122] However, more recent publications have brought forward the idea that
the effect of DBS may have both excitatory and inhibitory effects, depending on the orientation of
the neurons relative to the DBS contact, and other variable parameters. [123] In any case, some
experts theorize that it may be the interruption of pathological discharge in the basal ganglia that
decreases motor symptoms. In our model, DBS significantly increases firing rate, and because the
signal is directly connected to the neurons in the GPi, we assume that this is the correct result.
We then wanted to observe the effects of cortical rTMS in deep brain regions, so we added TMS
and connected it to the CTX nucleus. From Table 8, it is clear that TMS can decrease Parkinso-
nian synchrony with S = 0.26 for clinical TMS of 10 pulses/sec. By further increasing the TMS
frequency, we see even lower levels of synchrony; 50 Hz TMS gives synchrony levels very close
to that of a healthy GPi, with S = 0.09.
Thus, our model suggests that clinical TMS on the M1 region at 50 pulses/sec can lower the
synchrony level of the GPi close to that of a healthy GPi nucleus. Raster plots of the GPi can
be seen in Figure 73. We conclude that this new model showed a potentially viable non-invasive
alternative to DBS therapy using high-frequency rTMS. This phenomenon should be studied in
animal models as a next step.
The following pages show supplementary raster plots for visualization of changes in the motor
pathway nuclei firing for healthy, PD, DBS, and TMS models. Full Python code for this project
can be found in Appendix F. Also see the latest version of our manuscript below, which has been
submitted to IEEE Transactions on Biomedical Engineering.
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Figure 73: Raster plots of GPi ()healthy, PD, DBS, and 50 Hz TMS).
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Figure 74: Raster plots of all nuclei for healthy model. Red arrows indicate inhibitory connections
while blue arrows indicate excitatory connections.
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Figure 75: Raster plots of all nuclei for Parkinsonian model. Red arrows indicate inhibitory con-
nections while blue arrows indicate excitatory connections.
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Figure 76: Raster plots of all nuclei for Parkinsonian model with DBS at GPi. Red arrows indicate
inhibitory connections while blue arrows indicate excitatory connections.
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Figure 77: Raster plots of all nuclei for Parkinsonian model with cortical rTMS at 50 pulses/sec.
Red arrows indicate inhibitory connections while blue arrows indicate excitatory connections.
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6.4 3D Fiber Tract Modeling for Finite Element Simulations
The final step in this project was creating a segmented fiber tract model in which each tract bundle
is developed as a separate model piece. The hypothesis is that by using a high conductivity value
to model axonal conduction velocity, it may be possible to apply TMS on any part of the cortex
and observe signal propagation through the fiber tracts. Using these models, it may be possible
to observe stimulation of deep brain regions with cortical TMS. Past studies have shown that it is
possible to segment fiber tracts manually as well as by use of software. [56] [124] [125] However,
these models were limited to M1 fiber tracts and focused on characterizing the signal propagation
through these tracts. We were interested in developing a method to create fiber tracts from various
parts of the brain such that we could perform FEA simulations to visualize cortical/subcortical and
cortical/deep brain region paths.
We used the software ExploreDTI to find targeted fiber tracts which propagate from cortical to
deep brain regions. Figure 78 shows an example of some fibers created using Diffusion MRI data
from a healthy male patient in ExploreDTI. We were then able to export the vector data for these
fiber tracts, and, after some analysis, import this vector data into SolidWorks. Figure 79 shows
these fiber tracts imported into SolidWorks. Finally, we performed the sweep function for these
tracts to export them as solid 3D models, after which we were able to import these models into
Sim4Life and perform TMS to the cortical end of the tracts, as shown in Figure 81.
Because we now have this method of creating fiber tracts for FEA simulations, we can easily
create hundreds or even thousands of tracts for analysis from any part of the brain. This work
will be helpful in understanding which deep brain regions are affected by TMS on any part of the
cortex.
We are grateful to Jennifer Mak and Paxton O’Bryen for their invaluable contributions in creating
these fiber tract models.
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Figure 78: Fiber tracts developed in ExploreDTI.
Figure 79: Fiber tracts developed in ExploreDTI and imported into SolidWorks.
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Figure 80: Fiber tracts developed in ExploreDTI, modeled in SolidWorks, and imported into
Sim4Life as 3D models for FEA simulations of TMS. This figure shows the fiber tracts placed
inside their corresponding location inside a brain tissue model.
Figure 81: TMS performed on frontal cortex leads to stimulation of these fiber tracts.
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Transcranial Magnetic Stimulation is a non-invasive clinical therapy used to treat
depression and migraine, and shows further promise as treatment for Parkinson’s dis-
ease, Alzheimer’s disease, and other neurological disorders. However, it is yet unclear
as to how anatomical differences may affect stimulation from this treatment. We use
finite element analysis to model and analyze the results of Transcranial Magnetic
Stimulation in various head models. A number of heterogeneous head models have
been developed using MRI data of real patients, including healthy individuals as well
as patients of Parkinson’s disease. Simulations of Transcranial Magnetic Stimulation
performed on 22 anatomically different models highlight the differences in induced
stimulation. A standard Figure of 8 coil is used with frequency 2.5 kHz, placed 5 mm
above the head. We compare cortical stimulation, volume of brain tissue stimulated,
specificity, and maximum E-field induced in the brain for models ranging from ages
20 to 60. Results show that stimulation varies drastically between patients of the same
age and health status depending upon brain-scalp distance, which is not necessarily
a linear progression with age. © 2017 Author(s). All article content, except where
otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license
(http://creativecommons.org/licenses/by/4.0/). [http://dx.doi.org/10.1063/1.4974981]
INTRODUCTION
Transcranial Magnetic Stimulation (TMS) uses external time-varying magnetic fields to induce
electric fields within the brain to downregulate or upregulate targeted brain tissue. Although TMS
is currently only FDA approved to treat depression and migraine, it is also a promising treatment
for certain symptoms of Parkinson’s disease (PD), Schizophrenia, Obsessive Compulsive disorder,
and other neurological conditions.1,2 We use data obtained from the Human Connectome Project
(HCP), a study sponsored by the National Institute of Health which gathered a large amount of
Magnetic Resonance Images (MRI) from real individuals.3 In previous studies, we have shown Tran-
scranial Magnetic Stimulation induced in models developed using data from the HCP.4 Here, we
introduce models of Parkinson’s patients created using data obtained from the Parkinson’s Progres-
sion Marker’s Initiative (PPMI), a project which collected MRI images of patients with Parkinson’s
disease.5 We created head models of PPMI patients with the goal of comparing effects of TMS on
healthy individuals and those with Parkinson’s disease. It is well known that the structure of the
brain in Parkinson’s patients can vary drastically, depending on disease progression, due to lesions
which form on white matter surface.6,7 Furthermore, it is well known that brain volume generally
decreases with age as the brain shrinks, but this fact is variable with genetics and lifestyle.8 We
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2158-3226/2017/7(5)/056711/5 7, 056711-1 © Author(s) 2017
 
 
 
 
 
 
056711-2 Syeda et al. AIP Advances 7, 056711 (2017)
assert that these structural difference may influence the stimulation of the brain during TMS. To
study these effects and draw relationships between brain structure and stimulation effects, we com-
pare results of TMS simulations on models of healthy individuals (henceforth referred to as HCP
models) and Parkinson’s patients (PPMI models) of varying ages. We also include the highly het-
erogeneous models known as Duke and Ella, developed by the IT’IS Foundation using MRI data
of healthy individuals. We compute maximum E-field (Emax) induced in the brain as well as total
volume and surface of the brain which receives stimulation as well as the specificity of the induced
E-field. We compare these effects for patients of varying ages and discuss the implications for brain
stimulation.
SETUP AND CALCULATIONS
Simulations include commercial TMS Figure-of-8 coil run using current of 5000 Amps at a
frequency of 2.5 kHz. The TMS coils are situated 5 mm above the surface of the head in each
case, as shown in Figure 1. To find optimum power required to stimulate each patient’s brain tissue,
clinicians find the motor cortex area of the brain and induce enough stimulation to obtain a vis-
ible motor reaction (twitching of the hand), and this is called the motor threshold (MT). 120%
of MT is then used as the stimulation parameter in the targeted region of the brain. To mimic
clinical TMS, we define our stimulation threshold as half of the maximum E-field induced in a
particular model, which is close to MT for a healthy individual. Because Emax in each model
varies, we also define an absolute stimulation threshold of 50 V/m for purposes of comparison.
Then, we analyze the amount of brain volume stimulated, surface stimulated, and specificity, a
measure of how focused the E-field diffusion is in the brain tissue. We compute specificity by divid-
ing volume stimulated by surface stimulated. We show the results of both nominal stimulation,
which varies for each model, as well as stimulation above the absolute threshold of 50 V/m, for
purposes of clarity and comparison. Surface stimulation and specificity do not include the Duke
and Ella models due to IT’IS licensing restrictions. Biot-Savart Law and Maxwell’s equations
are used to calculate H-field, B-field, and E-field induced in the tissues, similar to our previous
publications.9–11
RESULTS AND DISCUSSION
Figure 2 shows electric field induced in two HCP models and two PPMI models. We compare
the induced electric field by analyzing the number of cells which receive stimulation above the given
FIG. 1. E-field induced on surface of two HCP models (top) and two PPMI models (bottom).
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FIG. 2. Two models demonstrating orientation of TMS coils.
threshold, both throughout the brain (volume stimulated), and on the surface of the grey matter
(surface stimulated). Stimulation threshold is first taken as Emax/2 and then as 50 V/m, for separate
comparisons.
A significant cause of stimulation variability is the distance between the brain and the scalp,
which increases with age. It is unclear how Parkinson’s disease affects this process, as it is possible
that the disease may cause structural differences in brain tissue.6 Figure 3 shows how the brain-
scalp distance varies with age in our models. The trend is much clearer with the younger healthy
individuals than for Parkinson’s patients. For this reason, we will compare all parameters using
brain-scalp distance, rather than age, as the independent variable. Figure 4 shows the maximum
E-field values induced in all models as brain-scalp distance varies. It is clear that in general, as
the brain-scalp distance increases, a lower maximum E-field value is induced in the brain tissue, in
both HCP and PPMI models. Because Emax varies for each model, and our stimulation threshold
is generally dependent on Emax, it is important to also choose an unconditional threshold to deci-
pher any trends between stimulation and brain-scalp distance. We take this absolute threshold as
50 V/m, because each model receives at least that value of stimulation. When this absolute threshold
is used, we use the phrase “absolute stimulation”. Figure 5 shows volume and surface stimulation in
each model as a function of brain-scalp distance. Relationships are much more obvious in the plots
utilizing the absolute threshold of 50 V/m. It is shown that as the brain-scalp distance increases,
volume stimulation and surface stimulation both decrease, which is intuitive given that the mag-
netic field decays as 1/r3, and any increase in the distance between the brain and the coil would
reduce the induced E-field significantly. Furthermore, we calculate specificity (volume stimulated
divided by surface stimulated) as a function of distance (Fig 6(a)), as well as a function of Emax
FIG. 3. Brain-Scalp Distance as a function of age, with blue data points representing healthy individuals and red data points
indicating Parkinson’s patients.
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FIG. 4. Maximum E-field values induced in each model as a function of brain-scalp distance.
(Fig 6(b))
.
Specificity as a function of distance does not show much of a trend, once again due to
the variability of Emax in each model. For this reason, then, we consider specificity as a function
of Emax, and discover a clear monotonically increasing relationship which seems to differ between
HCP and PPMI models. Models with high maximum E-field values also receive higher specificity of
stimulation.
FIG. 5. Volume of brain tissue and grey matter surface stimulated as a function of brain-scalp distance. 5a and 5b show volume
stimulated, 5c and 5d show surface stimulated.
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FIG. 6. Specificity with varying brain-scalp distance (a) and Emax (b).
CONCLUSION
While the volume, surface, and specificity vary drastically with between models, we are able to
discern clear trends when we observe these same parameters using the constant stimulation threshold
of 50 V/m. While general trends have been observed in the past between the patient’s age and brain-
scalp distance, these trends can differ drastically between healthy individuals and Parkinson’s patients.
In PPMI models, the variability in brain-scalp distance was much greater than in the HCP models. This
may be due to the disease or to age, both of which can alter brain structure.6,7 Furthermore, maximum
induced E-field can vary between patients of the same age. As Emax increases, the specificity is
monotonically increasing for both HCP and PPMI models. From these data, it is clear that stimulation
effects can vary drastically between patients of similar age and health status. The causes for this
discrepancy may be numerous, but we can infer from our results that stimulation effects are more
far more dependent upon brain-scalp distance than upon age and health. This implies that in order to
accurately determine TMS parameters for a particular patient, it is crucial to determine the brain-scalp
distance using MRI.
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Transcranial Magnetic Stimulation is an emerging non-invasive treatment for depres-
sion, Parkinson’s disease, and a variety of other neurological disorders. Many Parkin-
son’s patients receive the treatment known as Deep Brain Stimulation, but often
require additional therapy for speech and swallowing impairment. Transcranial Mag-
netic Stimulation has been explored as a possible treatment by stimulating the mouth
motor area of the brain. We have calculated induced electric field, magnetic field,
and temperature distributions in the brain using finite element analysis and anatom-
ically realistic heterogeneous head models fitted with Deep Brain Stimulation leads.
A Figure of 8 coil, current of 5000 A, and frequency of 2.5 kHz are used as simula-
tion parameters. Results suggest that Deep Brain Stimulation leads cause surrounding
tissues to experience slightly increased E-field (∆Emax = 30 V/m), but not exceed-
ing the nominal values induced in brain tissue by Transcranial Magnetic Stimulation
without leads (215 V/m). The maximum temperature in the brain tissues surround-
ing leads did not change significantly from the normal human body temperature of
37 ◦C. Therefore, we ascertain that Transcranial Magnetic Stimulation in the mouth
motor area may stimulate brain tissue surrounding Deep Brain Stimulation leads, but
will not cause tissue damage. © 2017 Author(s). All article content, except where
otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license
(http://creativecommons.org/licenses/by/4.0/). [http://dx.doi.org/10.1063/1.4974062]
INTRODUCTION
Transcranial Magnetic Stimulation (TMS) is a non-invasive neuromodulation technique which
utilizes external time-varying magnetic fields to induce electric fields within the conductive tissues
of the brain, thus downregulating or upregulating targeted regions. TMS is currently FDA-approved
for treatment of depression, but shows promise for treating Parkinson’s disease (PD), Schizophrenia,
Obsessive Compulsive disorder, and a variety of other neurological conditions.1 A primary concern
for clinicians when considering TMS therapy is the risk of tissue damage and seizure from over-
stimulation. In addition, for PD and Essential Tremor (ET) patients, a widely used treatment for tremor
control is Deep Brain Stimulation (DBS), in which one (unilateral) or two (bilateral) leads are placed
inside the brain to deliver current directly to the globus pallidus internus (GPi) or subthalamic nucleus
(STN).2,3 These leads are comprised of four electrodes, insulating material, and a wire running through
the center of the lead body. DBS is a reliable and successful treatment for controlling tremor; however,
PD patients often suffer from other symptoms, such as difficulty with speech and swallowing, which
are caused by dysfunction in the mouth motor area of the brain, which is not accessible to DBS leads.4,5
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In these cases, supplementary TMS treatment to the mouth motor area can be a significant benefit to
the patient’s quality of life. It has been unclear in the past, however, whether the E-field induced from
TMS would stimulate GPi and STN due to the conductive material within the lead. DBS provides
sufficient stimulation to these regions, therefore additional stimulation from TMS may be hazardous
to the patient’s health. Therefore stimulation in tissues surrounding DBS lead in the presence of TMS
must be considered. Limited work has been done to study these effects, with results indicating that
tissue damage may occur.6,7 However, we posit that the models used in these studies did not possess
the complexity needed to replicate the human brain, and that simulation with a heterogeneous head
model with accurate parameters may give dissimilar results. We use Sim4Life, a finite element analysis
software developed by Zurich MedTech, to perform such simulations. Additionally, while various
coil shapes and designs have been proposed in the past for increased focality and optimization,
we use a model of the commercial, FDA-approved Figure-of-8 coil to simulate a more realistic
scenario.8
SETUP
Protocol for the desired results requires accurate, anatomically realistic head models and quasi-
static solvers suitable for low frequency stimulation parameters. This study used the “Duke” model,
which has been developed by Zurich MedTech from MRI data of a real patient. This model includes
full heterogeneity, including a variety of brain tissues such as grey matter, white matter, cerebrospinal
fluid, and thalamus, with best estimates of density, conductivity, and permittivity parameters obtained
by Zurich MedTech.8 A frequency of 2500 Hz was used for a Figure-of-8 coil, which was operated
at currents ranging from 1000 to 5000 Amps and situated near the mouth motor area of the brain. A
Deep Brain Stimulation probe model was developed and simulated as “off”, with no current running
through the lead. Figure 1 shows a visualization of the setup and a comparison of the full and
FIG. 1. (a) Figure-of-8 coil positioned 5 mm away from model’s head, by mouth motor area. (b) DBS probe visibly propagating
through grey matter. (c) Full probe model with insulators (blue) and conductors (pink). (d) Simplified probe model in which
conductors and insulators are placed further apart for simulation ease. (e) Wire and wire insulation (green), which is included
in both full and simple probe models.
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TABLE I. Referenced values for probe materials used for simulations.
Specific Heat Thermal Electrical
Mass Density Capacity, c Conductivity Conductivity Relative
Material (kg/m3) (J/kg/K) (W/m/K) (S/m) Permittivity
Conductor (Platinum) 21,450 133 72 N/A for PEC N/A for PEC
Insulator 1780 1200 0.2 0 7
simplified DBS probe models. We model conductors in the probe as Perfect Electrical Conductors in
E&M simulations and as pure platinum in thermal simulations.
CALCULATIONS
Vector Potential, decoupled from the E-field, is calculated using the Biot-Savart Law, and
Maxwell’s equations are used to calculate H-field, B-field, and E-field induced in the tissues similar
to our previous publications.8–10 Previous work has cited charge density as a means of determining
the occurrence of tissue damage.6 However, current density is generally computed using time and
pulse durations. Our electromagnetic simulation is quasi-static, and we do not use discrete pulses but
rather a continuous source of current. Therefore, rather than using current density, we will instead
consider tissue damage as a function of heat.
We use the Transient Thermal Simulation allows to compute time-varying temperature distribu-
tion in tissue. This solver uses the Pennes Bio-Heat Equation, finds heat generation and heat transfer
in the time domain. Table I gives our referenced thermal values for probe materials.7,11,12
RESULTS AND DISCUSSION
We compute magnetic field, induced electric field and temperature in brain tissue surrounding
DBS lead to determine if presence of DBS lead will cause health issues in the patient. Excessive E-field
will lead to over-stimulation and consequently adverse effects such as motor contractions, tingling,
and mood changes, while excessive heat in brain tissue will cause tissue damage. Figure 2 shows major
results from simulations run using 5000 Amps. Increased E-field and temperature can be observed in
mouth motor area due to placement of the Figure-of-8 TMS coil. We position the DBS lead along the z-
axis, from cortex to basal ganglia, as is the case for patients with PD. Figure 2c shows a sagittal slice in
close proximity to DBS lead, and stimulation in tissues surrounding DBS lead can be observed. E-field
and time-varying temperature have been calculated and shown in Figures 3 and 4. Note that in Figure 3,
the maximum E-field induced in brain tissue is a linear function of the current value in the coils. While
the presence of DBS lead increased E-field induced by TMS in the surrounding tissue, the values were
smaller than the E-field induced in the mouth motor region of the brain. Therefore, in our simulations
the presence of DBS lead does not cause excessive stimulation in surrounding tissue. Additionally,
because PD patients receive electrical stimulation in the basal ganglia from DBS, clinicians must be
certain that no additional stimulation is provided to basal ganglia area from TMS. Figure 3 shows
that the E-field induced in basal ganglia tissue of the model is too low to cause stimulation. Finally,
Figure 4 shows time-varying temperature distribution in brain tissue. We first allowed the brain
model 5000 seconds to reach steady-state, then applied TMS from 5000 seconds to 6000 seconds,
and finally we allowed a second rest period to observe heat diffusion. Total simulation time was 10000
seconds. Maximum temperature in the model’s brain in all cases remained below 37.35 ◦C. Because
the overall typical body temperature is 37 ◦C, this variation can be considered negligible, especially
when considering heat diffusion in the body over time. Furthermore, while tissue surrounding DBS
lead can be seen to increase slightly in the presence of TMS, these temperatures remain below
37.15 ◦C in all cases. Simulations were performed on the model of a healthy patient with normal
vasculature and blood flow; therefore, the effect of decreased vasculature and blood flow is not shown
here.
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FIG. 2. (a), (b) Induced E-field on grey matter surface; scale: 0 – 213 V/m. (c) E-field through coronal slice; scale:
0 – 50 V/m. (d) Temperature of grey matter surface at 5900 sec; scale: 37 – 37.4 ◦C.
FIG. 3. Maximum values for E-field in motor mouth (MM) area, brain tissue surrounding DBS lead, and tissue in basal
ganglia (BG) area for various current values.
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FIG. 4. Time-varying temperature distribution in brain tissues during rest stage (1000 sec – 5000 sec), TMS (5000 sec – 6000
sec), and second rest stage (6000 sec to 10000 sec). Solid lines show Mouth Motor area tissue temperature while dashed lines
show temperature in tissue surrounding DBS lead.
CONCLUSION
In the recent past, studies have analyzed, either computationally or using simple physical models,
the effect of TMS on brain tissue. However, very few of these studies have replicated the presence
of Deep Brain Stimulation leads in a brain which receives TMS treatment. Those that have done so
have used simple spherical head models and non-commercial circular coil shapes. We use a complex,
heterogeneous, anatomically correct head model with a commercial double coil design, as well as a
DBS lead modeled using standard, commercial-grade DBS leads. We use the Finite Element Analysis
software, Sim4Life, to solve highly refined grids for electric field and time-varying temperature
distribution in brain tissue. Analysis of these simulations suggest that while the presence of DBS
leads may slightly increase the induced electric field in surrounding tissues, no overstimulation or
overheating occurs. Therefore, our computations indicate that while DBS is switched off, Parkinson’s
patients may safely receive TMS treatment in the motor mouth area for treating speech and swallowing
impairment.
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Abstract—Patients with advanced Parkinson’s Disease often
receive deep brain stimulation treatment, in which conductive
leads are surgically implanted in the brain. While DBS treats
tremor and rigidity, patients often continue to suffer from speech
and swallowing impairments, which involve cortical regions of
the brain. Because DBS is unable to treat these symptoms, the
addition of transcranial magnetic stimulation may be beneficial.
However, the potential electromagnetic interactions of the strong
magnetic fields from TMS on the conductive leads is unknown.
Objectives: To calculate induced current in DBS lead due to
magnetic fields from TMS.
Methods: We have created a novel complex 3D model of a deep
brain stimulation lead, along with 10 heterogeneous, anatomically
accurate head models of Parkinson’s patients and one healthy
control. We used Finite Element Analysis to perform simulations
of Transcranial Magnetic Stimulation of these 11 models with
the complex lead implanted in the brain.
Results: Simulations show that transcranial magnetic stimulation
will induce current values lower than normal DBS stimulation
current. Thermal analysis shows that there is a maximum
increase of 0.25◦ C after 30 minutes of stimulation at motor
threshold stimulation strengths.
Conclusion: Our computational simulations using complex mod-
els and clinical settings suggest that combination TMS/DBS
treatment will not cause over-stimulation in the brain.
Significance: The potential combination of TMS and DBS for
patients of Parkinson’s disease will not cause overstimulation in
the deep brain nuclei, and so may be safe for combination use.
Physical phantom trials are necessary to validate the computa-
tional simulations.
I. INTRODUCTION
Patients of Parkinson’s Disease (PD) suffer from debilitating
symptoms and complications, including bradykinesia, resting
tremor, shuffling gait, and rigidity as well as non-motor
symptoms including speech and swallowing difficulties. [7]
[8] [9] Although the symptoms initially respond to Levodopa,
a dopaminergic medication, symptoms can often become re-
fractory, or side effects can cause additional symptoms. [10]
[11] [12] In these cases, physicians recommend deep brain
stimulation (DBS) surgery, in which one or two electrical
leads are inserted into the subthalamic nucleus (STN) or
globus pallidus internus (GPi), and current is continuously
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delivered to these nuclei from a battery pack inserted into a
chest pocket.[13] [14] [15] DBS has been shown to effectively
eliminate motor symptoms in patients of both PD as well as
Essential Tremor. [13] [14] [16] However, one of the more
crippling symptoms of PD that is not treated by DBS is
hypophonic speech and swallowing difficulty (dysphagia). Not
surprisingly, hypophonia and dysphagia can seriously deterio-
rate quality of life and cause complications such as weight
loss, isolation and depression. [17] [18] [19] Importantly,
these symptoms typically present well after the other motor
symptoms have become problematic, thus most patients with
speech and swallowing symptoms will have received DBS by
the time of onset. The mouth motor area of the primary motor
cortex is thought to play a role in the pathophysiology of these
symptoms, and manipulation of this cortex through repetitive
Transcranial Magnetic Stimulation (rTMS) has been proposed
as a treatment option. [8] [20] [21] [22] [23] [24] rTMS is
a non-invasive neuromodulation therapy which utilizes time-
varying magnetic fields to induce electric fields in the patient’s
brain, thus stimulating neurons in the targeted region. [25] [26]
[27] However, the potential for electromagnetic interference
from the magnetic fields of rTMS with the conductive leads of
DBS has prevented serious consideration of the combination
therapy. Primarily, there is concern regarding eddy currents,
which are induced on conductive surfaces caused by time-
varying magnetic fields. It is hypothesized that B-fields from
rTMS may induce such currents on the surface of any conduc-
tive part of the lead, and this current would travel along the
lead down to the contacts, in turn stimulating the deep brain
nuclei which the contacts target. We posit that this issue has yet
to be studied with accurate models and parameters. In the past,
studies have considered the implications of combining DBS
with TMS, but we argue that these studies are quite limited.
Some have underestimated and oversimplified the geometrical
complexities of the lead and biological tissue.[4][28] Other
studies have not used clinical parameters of rTMS (current
frequency, motor threshold) or considered induced current
due to TMS B-fields on the conductive parts of the DBS
lead.[29][30] In addition, we are not aware of any studies as
of yet which have used the heterogeneous head models to
study the effects of TMS on full, implanted DBS leads. [1]
[2] [3] [4] These studies present mixed results, with a variety
of stimulation methods and scenarios. Here, we present our
calculations for a very specific situation – TMS performed
on the Mouth Motor Cortex with ipsilateral medially inserted
2TABLE I
PREVIOUS PUBLICATIONS STUDYING SAFETY OF COMBINATION TMS/DBS TREATMENTS.
Publication Methods Current Induced in DBS Leads Results/Notes
Kumar et. al. 1999 [1] Homogeneous phantom head model. 70 - 125 µA Induced current significantly
TMS at 100% intensity performed lower than DBS stimulation.
1 cm above leads. Voltage measured
between contacts.
Shimojima et. al. 2009 [2] Homogeneous phantom head model. >20 µC/cm2/phase Charge density too
TMS applied at various high for stimulation
locations along head model to be safely performed.
Impedance used: 1162 Ω
Kuhn et. al. 2011 [3] TMS at 100% intensity 0.2 - 2.8 V Voltage does not exceed
with DBS ON at 4V. DBS stimulation and TMS
Voltage measured between contacts. duration is too short
to cause stimulation.
Deng et. al. 2010 [4] Created full circuit from contacts Up to 83 mA. Induced current too high
to chest IPG. Did not use If DBS is OFF, for stimulation to be
full DBS lead geometry. current is only possible safely performed.
1.2 kΩ resistor with contacts. at V>5V.
Kuhn et. al. 2002 [5] Clinical investigation of 5 N/A Contralateral and ipsilateral
patients with bilateral DBS motor-evoked potentials were
and TMS in the Motor Cortex. induced in 3/5 patients from TMS.
No other complications reported.
Hidding et. al. 2006 [6] Clinical investigation of 8 N/A MEP latencies were significantly
Parkinson’s patients with DBS, shortened, possibly due to
and mono pulse TMS current induced from TMS.
in the Motor Cortex. No other complications reported.
Current work Computational simulations with full <2 µA. Induced current lower
heterogeneous head models and than DBS stimulation.
complex DBS lead model.
TMS is at mouth motor cortex and
medially positioned DBS is OFF.
DBS lead. A brief literature review outlining differences
between these publications and our present work, including
general methods and findings, is presented in Table 1.
We have previously studied the effects of TMS on a
conductive cylinder and individual lead contacts in deep
brain regions. We focused on the E-field induced in the
brain tissues surrounding the conductive probe and found
that although there was some slight increase in E-field in
the tissues surrounding the lead, E-field values did not come
close to the stimulation threshold.[31] However, that study
did not include the geometrical complexities of DBS wires
within the lead; these model details would enable a more
comprehensive study of TMS-induced current inside the lead
body. While E-field at the contact locations may not have
reached stimulation threshold, it is crucial to determine the
current induced in the conductive wires, as this current would
potentially lead to deep brain stimulation. In this study we
introduce a complex DBS lead model implanted into newly-
created anatomically accurate heterogeneous head models of
PD patients. We utilized a TMS coil model, based on the FDA-
approved coil, to explore the interference of TMS B-fields on
the DBS lead wire. Because we have in the past studied E-field
induced in the brain due to implanted conductive materials, in
this study we have focused only on calculating the induced
current in the lead wire, as well as subsequent temperature
variation in the brain tissues.
A. Deep Brain Stimulation
DBS leads are comprised of four electrodes which lie at
the site of stimulation, with four separate wires capable of
delivering current to each contact. Each wire is wrapped in
insulation so as to avoid interference with the other wires,
and there is further insulation that comprises the entirety
of the probe body. We based our DBS lead model on the
commercial Medtronic 3387 lead used across the board in
DBS surgeries. [32] Another issue that needs to be addressed
is the temperature variation along the lead and surrounding the
tissues when rTMS is administered for durations such as those
used in clinical settings. Earlier studies have reported thermal
analysis in simple spherical phantoms that use brine solution
to represent conductivity of the grey and white matter.[2] Here,
we report analysis of thermal simulations using anatomically
accurate models of PD patients with inserted DBS lead.
3B. Transcranial Magnetic Stimulation
rTMS is currently FDA-approved for treatment of drug-
resistant Major Depressive disorder, but has shown beneficial
effects for symptoms of other neurological conditions.[25][33]
[34] [35] During TMS, alternating current is run through a
figure-of-8 coil, which causes a time-varying magnetic field.
This B-field then propagates through the patient’s skull and
onto the brain cortex, where an electric field is induced and
neurons in the targeted cortical region are depolarized.[25][33]
[36] rTMS in the mouth area of the primary motor cortex may
help relieve hypophonia and dysphagia by similarly induced
plasticity. [20] [21] [22] Therefore, we targeted the inferior
primary motor cortex in our model, hereafter known as the
mouth motor area of the cortex. [37] [38]
C. Electromagnetic Issues
Because TMS induces a time-varying magnetic field, it is
important to consider the effects of TMS on conductive DBS
leads. From Faraday’s law of induction, it is clear that any
time-varying magnetic field will induce an electric field on a
conductive substance. It is possible that this B-field will induce
an E-field and subsequent eddy currents on the conductive
surfaces of the lead wires. In this study, we explore factors
which mediate the intensity of this current.
II. COMPUTATIONAL MODELS
A. DBS Lead
We have developed a novel, highly complex DBS lead in
SolidWorks, using parameters from commercially available
Medtronic lead 3387. [32] This model includes the entire lead
length coursing over the skull towards the burr hole where it
dives deep into the brain parenchyma. It is composed of the
insulating sleeve, four independent wires with wire insulation,
and 4 contacts at the lead tip. Figure 1 below shows details
of the probe model.
Figure 1. Detailed view of novel lead model. Note the
insulating sleeve (red) and separate wires (yellow) ending at
each contact (purple).
Generally clinicians use either bipolar configuation or
unipolar configuration of DBS. In the bipolar configuration,
current is delivered to one contact such that the voltage
difference between the contact and its neighboring contact
creates a sphere of potential at the stimulation location. In
the unipolar configuration, the generator case is the positive
and a single contact is negative. [39] [40] [41] The current
induced in either of these configurations, on the order of mA,
must be compared against current induced due to TMS B-
fields. Therefore, we have simulated these leads in the ”OFF”
position, with no direct current applied to the leads.
Furthermore, location of the lead tip is typically at similar
sites in each patient, at the Globus Pallidus internus (GPi) or
Subthalamic Nucleus (STN). However, it is also important to
note that the course of the additional lead body lying on the
surface of the skull is closest to the TMS coil. Therefore, it is
important to consider the distance between the lead and TMS
coil, as well as the orientation of the TMS coil, to correctly
calculate induced eddy currents on the DBS lead wire. In
this study, we have assumed that the surgeon has tunneled
the lead directly posteriorly towards the vertex so that the
subgaleal lead is relatively medial, while the TMS coils are
placed laterally and inferiorly to access the ipsilateral mouth
motor cortex. This setup is shown in Figure 2.
Figure 2. Setup of lead placement on skull surface.
It is important to note that due to excess model complexity,
we were unable to create a longer DBS lead model which
extends down to the patient’s chest area for connection with a
battery pack. However, we posit that this issue will not cause
significant changes in terms of electromagnetic calculations,
as the maximum induced current in the lead will occur in the
brain, closest to TMS coils.
B. Human Models
In the past, computational TMS studies have used sim-
ple, homogeneous, spherical models to represent the human
head.[28] [42] While these studies have been beneficial for
understanding general E-field induction in conductive material,
we posit that a more heterogeneous and complex model
is necessary. In this study, we have used newly-developed
head models created using MRI images of real PD patients,
downloaded from the online database ADNI PPMI. These
models include separate geometries for grey matter, white
matter, cerebrospinal fluid, skin, skull, and cerebellum, similar
to models developed in our previous reports. [43] [44] [45]
III. SIMULATIONS
We used the Finite Element Analysis software known as
Sim4Life, which has been developed by Zurich Medtech
4(www.zurichmedtech.com) for the purposes of simulating the
effects of EM fields on biological tissue. Figure 3 shows the
simulation setup of a model with the figure-of-8 TMS coil.
Note that the coil has been placed with the highest intensity
of B-field aimed at the mouth-motor area of the primary
motor cortex. We used the same setup for the newly-developed
Parkinson’s models and the healthy model.
The coils were modeled after commercial figure-of-8 coil by
creating 9 concentric circular coils for each half. Additionally,
to model the current directions, the two halves of the coils
were given equal amplitude current in opposite directions.
A. Low Frequency Vector Potential Simulation
Eddy currents were analyzed using vector potential calcula-
tions. [46] [47] [48] Therefore, the first step in simulating this
paradigm in Sim4Life was an Low Frequency (LF) Vector
Potential (VP) simulation, which allows for the insertion of
conductive materials within the brain tissue. This simulation
utilized the figure-of-8 coil as a source, with frequency 2500
Hz. This AC current then induced a time-varying magnetic
field, at which point the software calculated induced current
on the conductive surface of the DBS lead.
Figure 3. Model with implanted DBS lead and TMS coils
targeting mouth motor area.
B. Low Frequency Magneto Quasi-Static Simulation
Next, the LF Magneto Quasi-Static simulation was used
by sourcing the results of LF VP simulation. The software
calculated induced E-field on all biological tissue due to TMS
B-fields. Additionally, induced currents from the DBS lead
were utilized to find effects on the surrounding tissue.
C. Thermal Analysis
Finally, we used Sim4Life’s Thermal Simulation to find
heating effects in the brain tissue. Sim4Life uses the well-
established Pennes Bio-heat equation, shown below, to calcu-
late temperature variation due to electric fields and cooling
rate due to blood perfusion. [49] [50] [51]
ρc
∂T
∂t
= ∇(˙k∇T ) + ρQ+ ρS − ρbcbρω(T − Tb) (1)
where k is the thermal conductivity, Q is the specific
metabolic heat generation rate, S is the specific absorption
rate, ω is the perfusion rate, and ρ is the medium density.
ρb, cb, and Tb are the density, specific heat capacity, and
temperature of the blood, respectively.
D. Motor Threshold
Clinical rTMS requires the establishment of each patient’s
motor threshold (MT), i.e. the stimulation current at which the
patient’s motor evoked potential (MEP) is reached. [52] [53]
[54] Varying stimulation parameters are required due to each
patient’s varying anatomy, such as the brain-scalp distance.
[43] [55] [56] Generally, MT is established when the physician
uses the TMS coil to target, to best estimation, the hand region
of the primary motor cortex, then sweeps through a range
of currents until the patient’s thumb visibly twitches. In the
case of rTMS for treatment of Major Depressive disorder, the
physician will then shift the coils 5 cm anterior, attempting to
target the left Dorsolateral Prefrontal Cortex (DLPFC). [57]
[58] [59] In our models, MT was established by directly
targeting the primary motor cortex and computing the E-field
induced on the cortex. Similar to the clinical setting, varying
anatomy in our models caused varying MT values across the
model population. The current at the primary motor cortex was
increased until the well-established threshold of 150 V/m was
reached. [60] [61] [62]
E. Simulation Steps
For purposes of consistency, we stimulated each model at
its MT value, ensuring that the stimulation value at primary
motor cortex was 150 ± 1 V/m across the model population.
To do so, we performed a primary simulation without inserting
the DBS lead. Once MT was established for the model, we
inserted the DBS lead and performed a Vector Potential sim-
ulation to compute induced current on DBS lead due to TMS
at that particular model’s MT. The results of this simulation
were used as input for the EM quasi-static simulation. Finally,
the results of the EM simulation were used as input for the
thermal simulation.
F. Parkinson’s Patient Models
Due to the lead wire’s conductive nature, current induced on
any region of the wire will travel to the lead contacts. For this
reason we concerned ourselves with the location of the lead
wire with respect to the TMS coils. We targeted each model’s
left hemisphere for both DBS and TMS, and placed the DBS
lead at a medial location to maintain clinical consistency. All
PD models with implanted DBS lead can be seen in Figure 4.
5Figure 4. 10 PD models with DBS lead inserted in the deep
brain region close to the hypothesized area of GPi/STN.
Insertion regions differ slightly depending on anatomical
differences.
G. Power Analysis
We performed a power analysis to determine the number of
patient samples needed with use of the following parameters:
power of 0.8, null hypothesis 1 mA, with standard deviation of
0.5, so that the expected hypothesis is that the induced current
will be near the level of DBS stimulation. Finally, we used
0.1 as the alternative hypothesis, to represent anything below
DBS stimulation current. This power analysis gave a required
sample size of n = 5 models. In our study, combination
DBS/TMS treatment was simulated for 10 PD models and
1 healthy control model. These additional models gave us a
power of 0.999.
H. Coil Orientations
Finally, we staged various scenarios in which the TMS
coils were positioned at various orientations with respect to
the lead. The reasoning for these additional simulations was
that if in all cases the induced current values were also on
par with DBS stimulation current, then results would suggest
that combination TMS/DBS therapy is not safe for any setup.
These orientations are shown in Figure 5.
Figure 5. Various TMS coil orientations being tested on
healthy model with DBS Lead inserted. (a) and (d) show coil
set parallel to intraparenchymal lead. (b) and (e) show coil
set perpendicular to lead. (c) and (f) show coil placed close
to second set of conductive extensions that connect the lead
to the generator.
IV. RESULTS AND DISCUSSION
After performing TMS on the mouth area of the primary
motor cortex for all models, and subsequently finding Motor
Threshold, we inserted the DBS lead model and performed a
second simulation at MT. Importantly, it is the induced current,
rather than the E-field, which propagates through the lead body
and out to the tissue. Hence, we focused on induced current
in the lead wire. Sim4life can also calculate induced current
density on all surfaces, and we deduced the total current value
by multiplying current density in the wire (A/m2) by the
wire’s cross-section, using 0.05 mm as the wire radius.
It is important to note that we were not able to directly
compare either induced E-field or current density between the
lead and cortex. Due to complex geometries of the lead model,
Sim4Life could not accurately calculate E-field on the lead
body without discontinuities. On the other hand, calculated
current density on the cortex was meaningless, as Sim4Life
uses bulk conductivity value of grey matter for calculations,
rather than current induced on neuron bodies, which is the
contributing factor for neuron depolarization. Therefore, we
compared current induced in the DBS lead wire to current
supplied to DBS lead during constant current stimulation,
which is typically on the order of mA. [63]
It is important to consider the orientation of the B-field with
respect to the DBS lead. Therefore, we tested the effects of
placing TMS coils parallel and perpendicularly to the lead
body, as well as targeting the second set of conductors which
connect the lead wires to the battery pack. After performing
simulations and analyzing results, we found that orientation (a)
in Figure 5 induced the highest amount of current, most likely
due to the parallel nature of the lead wires with the magnetic
field; this orientation is similar to an inductive coupling set-up.
Additionally, we have two segments of the lead at essentially
right angles to each other - the segment targeting the deep
brain nuclei, and the segment which lies on the skull. However,
it is only the segment with the exposed lead contacts which
is clinically significant due to its interaction with TMS at the
mouth motor region. A schematic of the magnetic field in
this orientation can be found in the appendix. Induced current
results can be seen in Figure 6.
Figure 6. Current induced in lead wire for 6 orientations
shown in Fig. 5. Note that maximum current was induced
6with orientation a, which was subsequently used for all
models in Figure 7.
The overall goal of this project was to compare any stim-
ulation from TMS-induced current in the lead with DBS
stimulation parameters. To account for the worst-case scenario,
we used orientation (a) in Figure 5, which induced the highest
current value compared to all other orientations, most likely
due to the orientation of the B-field with respect to the
DBS wire loops. We used current density calculations from
Sim4Life simulations and converted to current in the cross sec-
tion of the lead wire by multiplying by pir2, with r = 0.05mm.
These calculations equaled the maximum current induced at
any point in the DBS wires and into the lead conductors.
Calculated current values for all models can be seen in Figure
7. Note that for all models, the current values are on the
order of µA, orders of magnitude below the constant current
values used for DBS (mA). For this reason, it is clear that
our simulations show that for a DBS lead positioned medially
in the patient’s head, TMS in the mouth area of the primary
motor cortex will not cause over-stimulation.
Figure 7. Current induced in lead wire for 11 models.
Finally, thermal simulations were performed for t = > 30
min, with TMS in the ”on” state from t = 20 to 50 min.
Initialization time of 20 min was given to bring all tissue to
their respective initial conditions, which placed various parts
of the brain between 37 and 37.3◦ C. TMS was then switched
on, and left on for 30 minutes, until t = 50 min. Cooldown
was then observed. The results show that although there is
slight increase in temperature in the tissue close to TMS coils
(Tmax = 37.45◦ C)as well as the DBS lead (Tmax = 37.3◦ C),
maximum temperature does not exceed 37.45◦ C in any part
of the brain, which is a negligible increase in temperature.
Temperature variation over time on the gray matter surface
can be seen in Figure 8.
Figure 8. Temperature variation on gray matter surface when
TMS is turned on for 30 min. Images are taken before the
start of TMS, at 10 minutes after the start of TMS, at 30
minutes, then at 10 minutes after TMS has been switched off.
Finally, the regions of highest temperature increase were
found for both the brain tissue and the lead body. Not
surprisingly, these regions were the mouth motor area, the
region targeted by TMS, and the the most conductive parts
of the lead, the contacts. These plots can be seen in Figure 9.
Figure 9. Temperature variation in region of highest
temperature increase in brain tissue (mouth motor area -
solid line) and at region of highest temperature increase in
DBS lead (lead contact - dashed line). Note that temperature
does not exceed 34.5◦ C.
Thus, our simulations found that while performing TMS in
the presence of DBS leads, there is no significant temperature
7increase in any part of the brain.
We believe that our simulations show a distinct lack of
over-stimulation due primarily to the scenario presented. Be-
cause we model DBS leads placed medially in the brain,
and TMS performed at the inferior motor cortex, there is
significant distance between the TMS coils and DBS leads,
particularly at the orientation which causes highest induced
current. Additionally, we use heterogeneous, highly accurate
head models, which have not been used in the past, as well as
clinical TMS parameters and a full DBS lead model complete
with wire insulation. It is important to note that while our
simulations show low induced current, they are only relevant
for the particular patient scenario presented in this work.
V. CONCLUSION
We have developed a complex Deep Brain Stimulation
lead model with all conductive parts, wires, and insulat-
ing body included. We inserted this model into 10 newly-
developed heterogeneous, anatomically accurate head models
of Parkinson’s patients as well as one healthy control model.
Using Finite Element Analysis with a model of FDA-approved
TMS coil, we performed simulations of TMS at the inferior
motor cortex on brain models which have DBS lead inserted
medially in the brain. We then calculated induced currents
on DBS wires due to time-varying B-field from TMS. To
account for anatomical variability across patient populations,
differences in DBS lead placement, and variability of TMS
treatments, we tested multiple coil orientations. We found that
for all models and coil orientations tested, induced current in
the DBS lead was in all cases orders of magnitude below
clinical stimulation current parameters (mA). This induced
current will not cause deviations from the patient’s normal
DBS stimulation paramaters, and so would not lead to over-
stimulation in the deep brain nuclei. Finally, we performed a
transient thermal simulation on the control model, wherein we
simulated TMS switched on for 30 minutes in the presence of
an inserted DBS lead. Calculated change in temperature was
negligible for both the cortical region targeted by TMS and the
DBS lead. Therefore, our simulations suggest that TMS at the
inferior motor cortex in the presence of medially-placed DBS
leads will not cause over-stimulation from electromagnetic
interference or overheating in the brain tissue. Further experi-
mental verification is required to ensure that clinicians may
safely perform TMS/DBS combination therapy, particularly
for patients who have more laterally-inserted DBS leads.
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 
Abstract—Transcranial Magnetic Stimulation is non-invasive 
neuromodulation therapy which uses time-varying magnetic fields 
to induce electric fields within the patient’s brain, thus allowing 
for neural stimulation of the targeted region. While past studies 
have used Finite Element Analysis to model the effects of 
stimulation in brain tissue, there have been limited studies which 
analyze the effects of the same stimulation on the neuron 
responses. We use a python package called NEST to model 
populations of neurons which are healthy as well as those that have 
diminished or absent myelin sheath. We model diminished myelin 
sheath by increasing the capacitance of the neuron. We study the 
effects of Transcranial Magnetic Stimulation on the synaptic 
activity of these populations by utilizing clinical parameters 
specific to Transcranial Magnetic Stimulation. Furthermore, we 
compare our results to models of brain tissue stimulation using the 
Finite Element Analysis software Sim4Life. Our results indicate 
that all neuron populations, regardless of their myelination state, 
retain some stimulation threshold which increases discretely as the 
myelin sheath diminishes. Using tissue analysis, we also computed 
the range of TMS current necessary to reach these stimulation 
thresholds for demyelinated populations. Furthermore, we find 
that the maximum induced E-field on the cortical surface does not 
exceed 220 V/m for stimulation of highly demyelinated neuron 
populations. Therefore our study finds that although 
demyelinated neurons exhibit much lower nominal synaptic 
activity than healthy neurons, they are nevertheless responsive to 
Transcranial Magnetic Stimulation, and these stimulation 
thresholds can be reached without inducing an unsafe maximum 
E-field on the cortex. 
 
Index Terms—Transcranial Magnetic Stimulation, Neuron 
Modeling, Brain Stimulation, Neuron Demyelination 
 
I. INTRODUCTION 
RANSCRANIAL Magnetic Stimulation (TMS) is a non-
invasive neuromodulation technique which is currently 
FDA-approved for treatment of major depression. TMS 
also shows beneficial effects for treatment of additional 
disorders of the brain, such as Alzheimer’s and Parkinson’s 
disease, but further research is required to fully understand its 
 
 
effects.[1][2] During TMS, a coil is placed near the surface of 
the patient’s head. An AC current flows through the coil, and a 
subsequent time-varying magnetic field is induced, which then 
propagates through the head and onto the surface of the brain. 
This B-field in turn induces an electric field in the conductive 
parts of the brain, which serves to excite neurons in the targeted 
area of the cortex. The particular location of this targeted region 
can vary depending upon the particular disorder being treated. 
While TMS is currently FDA-approved for limited usage, it is 
believed within the field that further research will enable 
clinicians to utilize TMS for treatment of a wide variety of 
neurological conditions. In the recent past, studies have shown 
the effects of TMS on brain tissue using simulations in Finite 
Element Analysis software and heterogeneous head models 
developed from MRI images of real patients [3],[4],[5][6]. 
These studies have improved the understanding of TMS on the 
brain with respect to safety, with regards to overstimulation or 
overheating in the brain. However, the mechanism behind TMS 
in the stimulation of the neurons, is little understood, despite its 
wide clinical use. While there have been groups who have 
modeled neurons in the past, there have been no studies that we 
are aware of which compute activity in neuron populations 
during Transcranial Magnetic Stimulation. We posit that a 
study of the neuronal activity during TMS would be beneficial 
to the basic understanding of brain stimulation.  
 One of the wide variety of physiological issues that can cause 
neurological disorders is demyelination of neurons. The myelin 
sheath in healthy neurons encloses the neuron shaft and aids in 
the propagation of electrical signals through the neuron body. 
Presence of myelin increases the voltage difference between the 
two ends of the long neuron body, thus allowing the electrical 
signal to jump across. When the myelin sheath begins to 
disintegrate, as is the case in Multiple Sclerosis (MS), Guillain-
Barré Syndrome (GBS), and a number of other diseases, the 
neuron capacitance increases, thus slowing down the signal 
propagation. With enough myelin disintegration, the signal is 
unable to pass on to the adjacent neuron.[7] This structure is 
shown in Figure 1.[8][9]  
In this study, we use a python-based neuron modeling 
software package called NEST to model neuron populations 
and study the effect of direct active stimulation on healthy and 
demyelinated neurons. Because TMS is performed on the 
cerebral cortex, we use parameters from past literature 
corresponding to cortical neurons in order to correlate induced 
E-field and current on the neuron. [10]–[14] We then compare 
this data to analysis of tissue stimulation using the Finite 
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Element Analysis software called Sim4Life, which has been 
used in past literature. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II. MODELING AND SIMULATIONS 
In NEST[15] all default settings for modeling simple, healthy 
neurons were utilized, then capacitance was gradually increased 
to model demyelination. As a first step, we simulated a single 
neuron with nominal incoming noise modeled by a Poisson 
(random noise) generator, which is commonly used to model 
normal neural activity.[16] Figure 2 shows the activity of a 
single healthy neuron in the presence of this Poisson noise.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note that the resting potential of neurons is -70 mV, and only 
after reaching a potential of -55 mV does the neuron fire, i.e., 
the voltage immediately drops back to its resting potential. 
Furthermore, in MS, it is mainly axons in the cortical region 
(near the surface of the brain) that undergo demyelination, 
therefore we will be focusing on the electric and magnetic field 
properties at the cortical region of the brain.[17] 
Electrical modeling of neurons can be quite variable as 
resistance values and axon sizes can significantly differ 
between neurons, thus significantly altering the current induced 
in the neuron membrane. For this study we use typical values 
of cortical neuron electrophysiology found in literature: 
diameter 1 µm, axon length 10 mm, and resistance 32 Ω.[10]–
[12] Utilizing these values, we calculated the E-field required 
to induce varying amounts of current in the axons. For 
additional calculations, we utilize a Finite Element Analysis 
software, Sim4Life, which is commonly used to calculate 
electric and magnetic fields in human tissue[3], [4]. We utilize 
Sim4Life to find correlations between E-field induced on the 
cortical white matter (axonal) surface and B-field on the surface 
of the TMS coil. These calculations are presented in Figure 3.  
For modeling of TMS in NEST, we used stimulation current 
frequency of 2500 Hz and pulse width of 0.4 milliseconds for a 
total of 10 pulses per second. Note that the current frequency of 
2500 Hz differs from the pulse frequency of 10 pulses/second. 
These parameters correlate to both past TMS models for brain 
tissue, as well as clinical constraints.[3] We model populations 
of 10,000 neurons, stimulating for a total of 10 pulses, or 1 
second. Lastly, to account for demyelination, we gradually 
increase the neuron capacitance from its nominal value of 250 
pF until the non-stimulated synaptic activity had decreased to 
less than 0.01%, which we consider to be demyelinated, at 290 
pF.   
Time (ms) 
Figure 2: Single neuron with normal firing. 
Figure 1: Neuron structure (left) and disintegration of myelin (right) 
[7, 8]. 
Figure 4: The Duke model (left) and images of grey and white matter 
(right).  
Figure 3: Calculated E-field values required to induce varying levels 
of current on cortical white matter.  
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The FEA software Sim4Life has been developed by Zurich 
MedTech for analysis of field profiles in biological tissue in the 
presence of electric and magnetic fields. Past studies have used 
Sim4Life to analyze the effects of TMS on brain tissues using 
heterogeneous and anatomically accurate head models.[3], [4] 
Zurich MedTech has developed and licensed these models 
using MRI data from real patients. We utilize Sim4Life and the 
model known as Duke, shown in Figure 4, and compare the 
results of the neuron model to the field profiles present in brain 
tissue. 
III. RESULTS AND DISCUSSION 
After simulating TMS with the above-mentioned clinical 
parameters, we find clear spikes in neuronal activity, which 
represent the stimulation threshold of these populations. To 
validate the accuracy of our model, we can compare the 
stimulation threshold of the healthy population to the 
established stimulation threshold of 150 V/m.[4], [18] Figure 4 
shows that by using the stated axonal parameters, our healthy 
neuron population displays a spike in activity at 40,000 pA. 
Figure 3 correlates this current value to an induced E-field on 
the white matter surface of around 130 V/m, which validates 
the relative accuracy of this neuron model. 
We then gradually increase the capacitance of the neuron 
population, from 250 pF to 290 pF, at which point the activity 
decreases to a total of 1 impulse per second, from the original 
value of ~85,000 total impulses per second for the population 
of 10,000 neurons. 
It is clear from Figure 5 that marginally demyelinated neuron 
populations (255-265 pF) retain the same stimulation threshold 
as that of the healthy population at around 40,000 pA. However, 
at 270 pF, a higher stimulation threshold of 50,000 pA is 
required, and for highly demyelinated neuron populations, 
those with capacitance greater than 280 pF, stimulation current 
of 60,000 pA is required, with overlapping data points for 285 
pF and 290 pF. 
The neural activity shown in Figure 5 is a suitable 
representation of what is currently known about brain 
stimulation. As stimulation current is increased, synaptic 
activity remains constant until the stimulation threshold is 
reached, at which point there is a clear spike in neural activity. 
Additional current does not induce any further spikes in 
activity. This data shows clear stimulation thresholds for 
healthy and demyelinated populations.  
Additionally, the change in number of impulses is closely 
related to the natural, non-stimulated, firing rate of the neuron 
populations, which varies with neuron type, but this study does 
not reach the extent of varying natural firing rates. Therefore, 
we can safely state that the clear increase in activity represents 
neuron stimulation, and although this preliminary model is 
useful for a basic understanding of the subject matter, the exact 
values of impulses needs further study if we want a more 
accurate, clinical understanding of the effects of TMS on 
neuron populations. 
Figure 5: Number of Impulses observed in each population as a function of increasing stimulation current.  
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Next, we utilize Sim4Life to calculate the electric field 
profiles that are required to reach these threshold current values. 
The data shown in Fig. 3 establishes that for values of 40,000 
pA, 50,000 pA, and 60,000 pA, the required E-field values are 
128 V/m , 160 V/m, and 192 V/m. Figure 6 shows the induced 
E-field on the cortical grey matter (GM) and white matter (WM) 
surfaces of the model known as Duke. 
 
It is important to note that because grey matter surrounds 
white matter, the induced E-field on grey matter surface is 
significant to ascertain the safety of these stimulation 
parameters. Due to the nature of the B-field, very small 
distances can cause large drops in field strength. For this reason, 
it is important to calculate the difference in induced E-field 
between white matter and grey matter. There is a clear variation 
in induced E-field values between the (surrounding) grey matter 
and (encased) white matter surface in Figure 7, which shows 
these calculated E-field values, as well as associated TMS coil 
current amplitudes. 
It is crucial to note that the horizontal axis in Figure 7 
represents the current in the TMS coil rather than the current 
induced in the neuron population. Due to anatomical variation, 
the TMS coil currents for nominal stimulation can vary 
significantly between patients.[4] Thus, the initial current value 
in Fig 7 is less significant than the current range of 5000 Amps. 
The data shows that between 134 V/m (~threshold 1) and 161 
V/m (~threshold 2) in the white matter, an additional 2000 
Amps are needed in the TMS coil. Another 2000 Amps are 
required to induce an E-field of 188 V/m (~threshold 3) in the 
white matter. 
These values signify the difference in TMS coil current 
required to stimulate healthy and demyelinated neurons, as 
shown in Figures 3 and 5. Our data shows that, in the above-
stated cases, the maximum E-field on the grey matter cortical 
surface does not exceed 220 V/m, which is generally considered 
a safe dosage.       
IV. CONCLUSION 
Transcranial Magnetic Stimulation is a widely-utilized 
treatment for major depression, and has shown beneficial 
effects for treatment of other neurological conditions. Although 
there have been some studies in the recent past calculating E-
field in human brain tissue as a result of TMS, the actual 
mechanism behind neural stimulation is not well-understood. 
We have developed a simple neuron population model using the 
python package NEST, and modeled the application of 
Transcranial Magnetic Stimulation to this population. We 
looked at healthy neurons as well as those that have undergone 
mild to severe demyelination as a result of demyelinating 
disorders such as Multiple Sclerosis. Our study correlated the 
induced electric field on the cortical white matter surface to the 
current induced on the axons. We then verified the accuracy of 
our model by comparing the resultant stimulation threshold in 
our model to the known stimulation threshold of 150 V/m, and 
we further found the stimulation thresholds in a variety of 
demyelinated neuron populations. We found that all 
populations, including completely demyelinated neurons, retain 
the ability to fire during TMS, albeit at a higher stimulation 
threshold. We calculated this threshold for each neuron 
population and showed correlated induced E-field on brain 
tissue as well as B-field required on TMS coil. We find that the 
necessary induced E-field values on the cortex for stimulation 
of demyelinated neuron populations does not exceed 220 V/m. 
Therefore, our study indicates that Transcranial Magnetic 
Stimulation can be applied effectively on demyelinated neuron 
populations with an increased stimulation threshold, and will 
result in a dramatic surge in synaptic activity during 
stimulation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 V/m 
150 V/m 
Figure 6: Induced E-field on grey matter (left) and white matter 
(right) for TMS coil current 10,000 Amps, as performed on Duke. 
Figure 7: Maximum induced E-field values on grey matter (GM) and 
white matter (WM) cortical surfaces. 
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1A Novel Computational Model to Study the Effects
of Non-Invasive Brain Stimulation on the
Parkinsonian Motor Pathway
F. Syeda, Student Member, IEEE, D. Kumbhare, M. S. Baron, R. L. Hadimani, Senior Member, IEEE
Abstract—Parkinson’s disease is a motor disorder affecting
millions of people. Patients with medication-refractory symptoms
often receive deep brain stimulation, a surgical procedure in
which current is delivered to deep brain nuclei. It may also
be possible to alter neuronal firing in these nuclei by perform-
ing non-invasive repetitive transcranial magnetic stimulation,
although downstream neuronal effects are difficult to observe
experimentally.
Objectives: To create a computational model of the basal ganglia
motor pathway and observe downstream neuronal effects of
rTMS.
Methods: We modeled healthy nuclei with background noise and
connection weights, then simulated parkinsonism by removing
dopaminergic input to the striatum. We modeled DBS current
delivery to the GPi in a parkinsonian brain. rTMS at various
frequencies was simulated at the level of the motor cortex, and we
observed predicted downstream firing rate effects and synchrony
at GPi.
Results: We have created an accurate basal ganglia motor
pathway model, with firing rates and patterns matching those
found in literature for both healthy and parkinsonian circuitry.
We performed DBS at the GPi and cortical rTMS at various
frequencies. Cortical rTMS at 50 pulses/sec led to desynchronous
firing rates and patterns at the level of the GPi.
Conclusion: Our simulations suggests that cortical, non-invasive
rTMS at 50 pulses/sec may have beneficial downstream desyn-
chronous effects in the deep brain nuclei which closely match
those seen in a healthy GPi.
Significance: This computational study suggests that rTMS at
certain frequencies may be a viable alternative to DBS surgery
for patients with Parkinson’s disease.
I. INTRODUCTION
Parkinson’s disease (PD) affects roughly 10 million people
worldwide.[1] Symptoms such as resting tremor, hypokinesia,
and rigidity can cause a drastic decrease in quality of life,
and in late stages of the disease, PD-related complications can
be fatal.[2][3][4] For treatment of medication-resistant motor
symptoms, physicians often recommend deep brain stimulation
(DBS), an invasive procedure wherein a lead is inserted into
either the subthalamic nucleus (STN) or the globus pallidus
internus (GPi). Programmable current is provided to these
F. Syeda and R.L. Hadimani are with the Department of Mechanical and
Nuclear Engineering, Virginia Commonwealth University, Richmond VA. D.
Kumbhare is with the Department of Neurosurgery, Virginia Commonwealth
University Health System, Richmond VA, and the McGuire Research Institute,
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M. Baron is with the Southeast PD Research, Education and Clinical Center
(PADRECC), Hunter Holmes McGuire Veterans Affairs Medical Center,
Richmond, VA, and the Department of Neurology, Virginia Commonwealth
University Health System, Richmond, VA.
nuclei via the lead, which is connected to a battery pack
implanted in the patient’s shoulder/chest area. [5] [6] [7]
DBS has been shown to ameliorate tremor, bradykinesia, and
rigidity in PD patients, and is also used to treat essential
tremor (ET). [5] [7] [8] While this technology has undoubtedly
changed lives, the invasive nature and cost of the procedure can
invoke major burdens for patients. We posit that if the neuronal
circuitry involved in these deficits can be traced, modeled, and
simulated, then non-invasive treatments may be explored.
In particular, we are interested in the effects of repetitive
transcranial magnetic stimulation (rTMS), a non-invasive brain
stimulation technique which is currently FDA-approved for
treatment of major depressive disorder (MDD), as well as
symptoms of migraine. [9][10][11] TMS uses alternating cur-
rent in a Figure-of-8 coil to create a time-varying magnetic
field. This magnetic field then propagates through the patient’s
skull and onto the surface of the brain, where due to the brain
tissue’s inherent conductivity, an electric field is induced, and
neurons in the targeted region are depolarized. [12] [13] [14]
One major limitation of TMS is that only cortical areas
can be directly targeted. Due to the rapidly-decreasing nature
of the magnetic field, deeper nuclei are out of reach if safe
parameters are upheld. On the other hand, TMS is a com-
pletely non-invasive outpatient procedure with the potential to
indirectly manipulate deep structures. Currently, MD patients
undergo TMS therapy for five days a week, 30 minute sessions
for 4-6 weeks. With these parameters TMS has been shown
to significantly improve symptoms which were previously
medication-resistant.[12] [13] [15]
While TMS is clearly effective in the treatment of some neu-
rological conditions, the exact mechanism by which it works is
poorly understood. It is clear that cortical neuron stimulation
leads to activation of neurons in deeper regions, but the details
of this mechanism are unclear. Single neuron and neural
network models have been developed in the past, but as far as
we know, none have been created for the purpose of studying
the effect of TMS on deep regions of the brain. Here, we
introduce a neuron network model using the software package
called NEST.[16] This model incorporates the basal ganglia
motor pathway which is thought to cause motor symptoms in
PD. We created a model of a healthy motor pathway by using
background signal and connection data found during in vivo
studies.[17] We simulated PD by removing dopaminergic input
to the striatum (STR), and the resulting simulated circuitry
showed indications of neuropathophysiology matching that
which has been seen during in in-vivo parkinsonian/dystonic
2humans and monkeys. [17] Next, to observe simulated local
and downstream neuronal effects of DBS, we modeled DBS
current input to the GPi in a parkinsonian brain. Finally, we
modeled current from TMS input to the cortex (CTX) and
observed this signal propagation along the basal ganglia motor
pathway.
II. BASAL GANGLIA CIRCUITRY AND PD PATHOLOGY
There are three pathways to consider in the modeling of
basal ganglia motor circuitry (Figure 1). These are the ‘direct’
pathway, thought to facilitate voluntary movement, and the
‘indirect’ pathway, thought to suppress involuntary movement,
and the ’hyperdirect’ pathway, which connects the cortex
directly to the subthalamic nucleus. [17] [18] The motor path-
way contains multiple inhibitory and excitatory connections,
and has been modeled and studied in depth. We use these
previously developed structural models to develop our own
functional computational model with accurate connections.
In the parkinsonian state, dopaminergic neurons present in
the SNc are destroyed, significantly limiting dopaminergic in-
put to the striatal dopaminergic D1 and D2 neurons. Following
the inhibitory and excitatory connections of the basal ganglia
shows that while some signals would be decreased, others
increase due to disinhibition, which is caused by suppression
of inhibitory signals, thus increasing the signal output. This
chain of events leads to a change in GPi output signals, and
these too have been recorded experimentally and reported in
past literature. [19] [20] [18]
Here, we present a computational open-loop motor pathway
model, the structure of which is based on the structural
circuitry shown in Figure 1. We study the effects of TMS
on parkinsonian pathology using simulations of this model.
Our results show that our model is, for the most part in
agreement with previous in-vivo studies in its firing and
connection weights, as is discussed in detail in the next section.
Additionally, we are largely interested in the downstream
effects of cortical TMS, and for this purpose, an open-loop
model gives good accuracy.
III. NEURON MODELING
NEST has been developed to focus primarily on modeling
neuron networks rather than individual neurons with variable
morphologies.[16] Hence, we use the simple leaky integrate-
and-fire neuron model to explore individual nuclei in the cir-
cuitry. Using a single-cell model we can observe the electrical
behavior of the neurons. Figure 2 shows a single neuron
in NEST, receiving randomly-generated noise as input. This
plot shows clearly that the neuron fires only after reaching
a membrane potential of -55 mV. Here, the integrate-and-fire
neuron model’s voltage simply falls back to resting potential
after firing, rather than reaching the maximum voltage value
of 40 mV. However, in this study we are interested in the
firing patterns rather than voltage potential, therefore this
model is effective for our simulations. In order to simulate
self-pacing neurons, we additionally add current generators to
model background noise for each nucleus.
Fig. 1. Structural model of healthy basal ganglia motor pathway (left) and parkinsonian pathway (right). Blue lines correspond to excitatory connections
while red lines correspond to inhibitory connections. Notice that in the parkinsonian condition with reduced dopaminergic input, thicker lines depict increases
in signal propagation and thinner lines depict decreases in signal propagation.
3Fig. 2. Single neuron response to randomly generated Poisson noise input.
Note that in NEST, the integrate-and-fire neuron does not exceed a voltage
value higher than -55 mV. Therefore, after firing, the voltage falls back to
resting potential rather than reaching the maximum 40 mV as is often seen.
Using NEST, modeling single neurons is relatively simple; it
is the connection between populations that becomes complex.
The type of connection, or synapse, between two neurons
is governed by the neurotransmitter present at the synapse
site. Glutamate is one of the neurotransmitters responsible
for excitatory synapses, while γ-aminobutyric acid, or GABA,
is one of the major inhibitory neurotransmitters.[21][22] The
neurotransmitter dopamine has variable effects on nuclei de-
pending on many factors including the neuron receptor type.
[23] [24] In NEST, and therefore in this computational model,
connections are specified as simply excitatory or inhibitory.
Additionally, neural networks require synaptic weight inputs to
determine the connection strength between two populations. In
neural networks developed for machine learning, these weights
are “learned” by the program based on some previously-
determined output. Similarly, we hard-code synaptic weights
between populations based on the nominal values of impulse
frequency found in past literature. [17] [25] [26] [27] [28] [29]
[30] [31] [32] The weights used are those that give accurate
output signals.
IV. MODELING PARAMETERS
The NEST software requires hard-coded values of synpatic
weights, and these weights, along with any background noise
introduced to the neurons, directly influence the firing behavior
of any given neuron. We found firing rates of each relevant
nucleus found in experimental studies, given in Table I.
We then found that the optimum number of neurons per
nucleus was 800, as less than 800 neurons did not provide
enough connections, and more than 800 did not change the
response, but did increase computational time. Additionally,
we found background noise and connection weights which
give output signals closest to those found in the literature.
The background noise should be relatively randomized so as
to prevent signal synchronization, but a range does need to
be specified to allow for output control. In NEST, we cre-
ated Poisson noise generators, with excitatory and inhibitory
TABLE I
APPROXIMATE FIRING RATES FOUND IN EXPERIMENTAL STUDIES, WHICH
WERE USED AS KNOWN OUTPUTS FOR OUR FUNCTIONAL MOTOR PATHWAY
MODEL.[17] [25] [26] [27] [28] [29] [30] [31] [32]
Nucleus Healthy Firing (Hz) Parkinsonian/Dystonic Firing (Hz)
CTX 5 N/A
STR 1 10
SNc 2 N/A
GPe 70 60
STN 20 40
GPi 70 90
effects, and varying range of frequencies with connections to
each nucleus, with connection weights given in Table II.
TABLE II
POISSON NOISE GENERATOR PARAMETERS FOR EACH NUCLEUS.
EXCITATORY = 8300 - 8500 HZ; INHIBITORY = 2000 - 2100 HZ
Nucleus Excitatory Conn. Inhibitory Conn.
Cortex 1.1 -1.28
Striatum (D1) 1.0 -1.1
Striatum (D2) 1.0 -0.85
SNc 1.0 -0.9
GPe 1.3 -0.5
STN 1.15 -0.9
GPi 1.1 -1.4
Once each nucleus was given a background signal, we
created the necessary connections between the nuclei in ac-
cordance with the motor pathway model shown in Figure 1.
We found the following connection weights to be optimum.
TABLE III
CONNECTION WEIGHTS BETWEEN NUCLEI AND DELAYS AS FOUND IN
LITERATURE.
Nuclei Connected Exc.(+) or Inh. (-) Weight Delay (ms)
CTX - STN + 1.0 5.9
CTX - STR + 0.1 5.1
SNc - STRD1 + 1.0 0.5
SNc - STRD2 - -5.0 0.5
STRD1 - GPi - -2.0 4.0
STRD2 - GPe - -5.0 5.0
GPe - STN - -0.3 4.0
STN - GPi + 1.2 1.5
STN - GPe + 1.0 2.0
We also modeled DBS current with frequency 185 Hz,
pulse width 0.09 ms, and current amplitude 0.1 mA as per
parameters used at the VCU Medical Center as well as those
found in literature.[33] TMS-induced current was modeled as
with frequency 2500 Hz, pulse frequency varying between 10
and 60 pulses/sec, pulse width 0.4 ms, and current amplitude
40,000 pA. In the past, we have found this parameter to be the
most accurate representation of current induced on the neuron
body by TMS. [34]
V. RESULTS AND DISCUSSION
Using the above-discussed parameters, we first ran the
simulation with healthy circuitry to observe firing rates and
patterns. To model Parkinsonian pathology, we simply re-
moved the connection between the dopaminergic input from
4TABLE IV
APPROXIMATE FIRING RATES FOUND IN OUR MODEL VS. EXPERIMENTAL STUDIES. [17] [25] [26] [27] [28] [29] [30] [31] [32]
Nucleus Healthy (Hz) (Experiment) Healthy (Hz) (Model) Parkinsonian (Hz) (Experiment) Parkinsonian (Hz) (Model)
CTX 5 7 N/A 7
STRD1 N/A 4 N/A 0
STRD2 N/A 4 N/A 9
SNc 2 3 N/A 2
GPe 70 66 60 44
STN 20 21 40 36
GPi 70 69 90 76
the SNc to STR. The resulting firing output in the GPi was
drastically changed for much of the circuitry. Parkinsonian GPi
output became highly synchronous and bursty, in contrast to
the random asynchronous firing observed in the healthy model.
The transition from asynchronous healthy to bursty PD GPi
firing has been observed in experiments from various studies
in the past. [19] [20] Thus, this finding helped to validate the
connection weights for our model. However, it was still crucial
to compare the firing rates of all nuclei in our model to those
observed experimentally, as well as to quantify the burstiness
and synchrony of our neuronal populations. To observe the
average firing rates for each nucleus, we took the total number
of impulses recorded for each nucleus and divided by the
total number of neurons (800). Although each iteration gave
slightly variable firing rates (± 10%), the mean for healthy
and parkinsonian/dystonic outputs are given in Table IV, along
with values from Table I, firing rates found in experimental
studies.
We also quantify the population’s synchrony, or the ten-
dency of the neurons to fire simultaneously at any given
timestep. We calculate the synchrony S of the system such that
if S = 1, the populations is completely synchronized, whereas
S = 0 means complete asynchrony. For a population of N
neurons firing in complete synchrony, the firing rate at any
given timestep would be either N or 0. Assume then that the
mean firing frequency µ = N/2. Then the minimum signal
frequency, fmin = 0, while the maximum signal frequency
fmax = N , and thus the standard deviation σ = N/2. The
range, fmax − fmin = N . In this case, then,
2σ
fmax − fmin =
2(N/2)
N
= 1 (1)
On the other hand, for a completely asynchronous system,
we assume µ = N/2. Then, σ would approach zero, and
therefore,
2σ
fmax − fmin = 0 (2)
In turn, we quantify the system’s synchrony as follows:
S =
2σ
fmax − fmin (3)
with S = 0 for complete asynchrony and S = 1 for complete
synchrony.
It is important to note that while we modeled all nuclei
discussed above as part of the motor pathway, we will be
discussing results primarily for the GPi nucleus. We model
DBS as applied to the GPi as a treatment for PD, there-
fore we will observe changes in the GPi. Using the above-
discussed quantification system, we perform simulations for
motor pathways that are healthy, parkinsonian, receiving DBS
stimulation, and receiving hypothetical downstream effects of
cortical rTMS at various pulse frequencies. We quantify the
synchrony of the GPi for each scenario. Table V shows firing
rate and synchrony data for the GPi in our model. Note also
that for modeling accuracy, we allow the model 0.5 seconds
to initialize, then run the simulation for an additional second.
Using our synchrony quantification, it is clear that naturally,
a healthy GPi in our model is mostly asynchronous, with S
= 0.08. The onset of PD, however, heavily synchronizes the
neurons, with S = 0.52. This is a well-observed phenomenon,
which we can now quantify with our model and synchrony
calculation. Next, applying DBS directly to the parkinsonian
GPi increases the total firing rate but also the synchrony to S
= 0.62. The effect of DBS on surrounding neurons has been a
subject of debate among experts. Many researchers argue that
DBS inhibits local neurons, the equivalent of lesioning the
nucleus. [35] [36] [37] More recent work has found that DBS
TABLE V
FIRING DATA FOR GPI IN OUR MODEL.
Model Standard Deviation σ favg (impulses/sec) fmin (impulses/timestep) fmax (impulses/timestep) Synchrony S
Healthy 5.68 72 1 128 0.08
Parkinsonian 37.30 82 1 144 0.52
DBS @ GPi 248.39 122 1 800 0.62
TMS(10 Hz) 25.26 80 1 240 0.21
TMS(20 Hz) 26.88 80 1 233 0.23
TMS(30 Hz) 25.29 80 1 236 0.21
TMS(40 Hz) 15.00 87 1 230 0.13
TMS(50 Hz) 9.78 87 1 230 0.09
TMS(60 Hz) 16.64 82 1 239 0.14
5may cause a combination of excitation and inhibition.[38] [39]
[40] In our model, the addition of DBS increases the firing rate
and synchrony, and so we assume that given our parameters,
this is an accurate representation. It is also possible that by
stimulating these neurons at roughly double their normal firing
rate, they may become over-discharged with signals and es-
sentially ‘turn off’. While this phenomenon needs more study,
our model simply shows a much higher firing rate, possibly
because this phenomenon is not included within NEST. Next,
we see that removing DBS and applying cortical rTMS gives
interesting results, as the level of synchrony naturally depends
on the pulse frequency of TMS. Downstream effects of clinical
rTMS at 10 Hz seems to actually decrease the synchrony of
the GPi, with S = 0.21. Further increasing the pulse frequency
gives slightly varying results, with 50 Hz giving the lowest
amount of asynchrony (S = 0.09), very close to natural healthy
asynchrony (S = 0.08). However, by increasing TMS pulse
frequency even further, we begin to see synchrony increasing
again. Therefore, our simulations suggest that clinical rTMS
may have synchrony-decreasing effects on the GPi up to a
certain frequency, and furthermore, rTMS at 50 pulses/sec may
bring the GPi to an asynchrony level very close to that of
a healthy GPi. We have created raster plots to demonstrate
neuron firing for a total of 1 second, between 0.5 seconds
to 1.5 seconds. GPi raster plots for healthy, PD, DBS, and
cortical TMS at 50 Hz can be seen in Figure 3. Raster plots
for other nuclei can be found in the appendix.
Fig. 3. Raster plots of healthy, PD, DBS, and 50 Hz TMS. Note the increased synchrony in PD GPi, and the higher asynchrony with downstream effects of
50 Hz rTMS.
6VI. CONCLUSION
We have developed a new computational model for an
open-loop basal ganglia motor pathway, with M1 cortical
and basal ganglia nuclei. We used experimentally-measured
firing rates for healthy and parkinsonian/dystonic nuclei and
connection delays, from previous literature, to validate our
model. Each nucleus was initialized to its correct background
activity with connections of varying levels of random noise.
We suppressed the connection between dopaminergic input
from SNc to STR and verified that the resulting firing rates and
patterns matched those found in parkinsonian (and dystonic)
nuclei. This verification also validated the connection weights
between all nuclei. With the verified parkinsonian pathway,
we then added a DBS signal connected directly to the GPi
to model DBS treatment and measured the firing rates and
synchrony within the GPi. Finally, to model cortical rTMS,
we removed DBS and applied rTMS signal to the cortex,
at clinical frequency of 10 pulses/sec, as well as increasing
frequencies up to 60 pulses/sec. Our simulations found that
DBS increases the firing rate but also the synchrony of the
GPi nucleus, while downstream effects of clinical rTMS may
illicit lower levels of synchrony; furthermore, higher frequency
rTMS of 50 pulses/sec may cause asynchrony very close to
that of a healthy GPi nucleus. We argue that this investigation
may have opened up an opportunity to study a non-invasive
alternative to DBS for patients with PD.
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.Conclusions and Contributions
Our work in macroscopic brain tissue simulations aided in answering some important questions
about TMS field profiles in patients of varying ages and brain volumes. The two-phase DBS
lead model project showed that for certain patients with implanted DBS leads, cortical TMS at
the mouth motor region may benefit treatment of speech and swallowing symptoms without over-
stimulating the deep brain regions and negatively impacting DBS treatment. Our new, neuron-
based motor pathway model provided some very significant insights regarding the effect of M1
rTMS in the basal ganglia nuclei. Simulations showed that high-frequency rTMS may have bene-
ficial effects for motor symptoms in Parkinson’s Disease. Because rTMS has been shown to induce
more long-term plasticity than DBS, this study may be a starting point for animal studies showing
the potential use of rTMS as a non-invasive alternative to DBS. Finally, our new method of creat-
ing 3D models of fiber tracts will be helpful in studying the potential deep brain effects of various
TMS modalities. The addition of fiber tracts in a 3D head model during FEA simulation will give
much more significant data regarding signal propagation rather than simple tissue stimulation in-
formation. The combination of brain tissue, neuron network, and fiber tract models will allow for
significantly deeper understanding of the mechanisms behind Transcranial Magnetic Stimulation
and enable clinicians to make more informed decisions about patient treatment. Furthermore, our
novel studies of motor pathway stimulation and deep brain effects of TMS will enable transla-
tional researchers to develop new non-invasive treatments for specific deep brain regions. TMS is
capable of inducing synaptic plasticity, but at the moment, a lack of understanding prevents the
treatment from reaching its full potential for patients of other neurological conditions. This project
will contribute to the clinical field by allowing development of new non-invasive brain stimulation
treatments through a greater understanding of the effects of cortical TMS on deep brain regions.
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7.1 Future Work and Recommendations
Because this thesis project was purely computational, there is much work that can be done to
follow up on simulation results. An anatomically-accurate, heterogeneous brain phantom should
be developed to compare with Sim4Life simulation results. A real DBS lead can be inserted into
such a phantom and TMS can be performed on the phantom’s cortical region, and the amount of
current induced in the DBS lead can be measured directly.
The next steps in our motor pathway model require animal studies, using animals with similar
motor pathway layout as humans. These animal’s deep brain regions can be lesioned to induce
dystonia or PD, as is currently done in Parkinson’s Disease studies. Then, rTMS should be per-
formed at the M1 region for these animals, and motor symptoms should be monitored over the
course of the treatment. If the animal studies show an improvement in motor symptoms through
TMS-induced plasticity and basal ganglia asynchrony, then this finding would be a breakthrough
in PD treatment research.
Finally, our method for developing 3D fiber tract models should be used to develop a variety of
fiber tracts from all cortical areas. Once developed, these models can be used in FEA simulations
of TMS to either study how certain treatments may cause signal propagation to various parts of the
deep brain region, or conversely, to find the cortical regions which should be targeted to stimulate
certain deep brain areas non-invasively.
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anatomical variability in brain on TMS treatment”, APS March Meeting 2017. New Orleans, LA.
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[5] F. Syeda, A. Pandurangi, A. El-Gendy, and R. L. Hadimani, “Effect of Transcranial Magnetic
Stimulation on Demyelinated Neuron Populations”, IEEE Intermag Conference. Dublin, Ireland.
April 24 - 28, 2017.
[6] F. Syeda, A. Pandurangi, A. A. El-Gendy, and R. L. Hadimani, ”Effect of Transcranial Mag-
netic Stimulation on Parkinsonian Neurons”, 63rd Annual Conference on Magnetism and Magnetic
Materials. Pittsburgh, PA. Nov 6 - 10, 2017. Oral.
[7] F. Syeda, A. Pandurangi, D. Kumbhare, M. Baron, K. Holloway, R. L. Hadimani, ”Effect of
Transcranial Magnetic Stimulation on Parkinsonian Motor Neurons”, APS March Meeting 2018.
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[8] J. Mak, F. Syeda, R. L. Hadimani, ”3D Modeling of Diffusion Tensor Imaging Tractography
Data for Finite Element Analysis”, IEEE ISBI 2018 Conference. Washington, DC. April 4-7, 2018.
Poster.
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.Appendices
Volume Stimulated Code
The following pages show the Matlab code we have written to calculate the amount of cells in the
brain tissue which are stimulated above a given threshold. We use the volume stimulation data
extracted from a Mask Filter from Sim4Life as imported data.
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1%Volume Stimulated Calculations for Sim4Life simulations of TMS
%Farheen Syeda
%August 2016
%This script takes input data from Sim4Life and finds the volume
 stimulated
%in a brain model after TMS simulations. Take the final output and
 multiply
%by 100 to get the percent stimulated.
%To find volume stimulated for each model, follow these instruction:
%Perform Sim4Life simulation with grid priorites set to 0 to ensure
%that each grid is same size. When the simulation is complete, in the
%analysis tab, create a Mask Filter which includes only the brain
 tissue,
%make sure to hit refresh, and export it as a matlab file. Then,
 import
%the file into matlab. During import, deselect Axes 1-3, and rename
%"Snapshot0" to "testmodelSnapshot0" or "NameofModelSnapshot0".
%If model name is numeric, add "M" in front of name to avoid issues.
%Finally, copy and paste "testmodel" section below, and find and
 replace
%each instance of "testmodel" with the new model name.
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%
%DO NOT GET RID OF OR REPLACE THE TESTMODEL SECTION
%COPY AND PASTE IT INSTEAD
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%
%If you have any questions about these instructions, I can be reached
 at
%syedaf2@vcu.edu
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%
%COPY AND PASTE THE BELOW SECTION. REPLACE 'testmodel' WITH the model
 name.
%testmodel
%set waitbar
h = waitbar(0,'Calculating for testmodel ...');
%Convert E-field data to RMS
Snapsize = size(testmodelSnapshot0,1);
2Avg= ones(Snapsize,1);
for i= 1:size(testmodelSnapshot0,1)
    Avg(i) = sqrt((testmodelSnapshot0(i,1)^2 +
 testmodelSnapshot0(i,2)^2 + testmodelSnapshot0(i,3)^2)/2);
    waitbar(i / Snapsize)
end
close(h);
ImagAvg = imag(Avg);
%find max e-field value
m = max(ImagAvg);
testmodelm = m;
%Declare thresholds
t = 100;
t2 = 150;
%Find total number of cells above threshold
count = 0;
count2 = 0;
for i=1:size(ImagAvg)
    if ImagAvg(i)>=t
        count = count+1;
    end
    if ImagAvg(i) >= t2
        count2 = count2+1;
    end
end
testmodelVS = count/Snapsize;
testmodelVS50 = count2/Snapsize;
clear i Avg count count2 ImagAvg Snapsize m t t2 h
disp('testmodel Completed...')
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%
Published with MATLAB® R2015a
Surface Stimulated Code
We have written the following Matlab code to calculate the amount of cells on the gray matter
surface which are stimulated above a given threshold. We import surface stimulation data extracted
from Surface Viewer in Sim4Life.
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1%Farheen Syeda
%Surface Stimulation Calculations
%Varying MRI Paper 2016
%September 12, 2016
%Surface for testmodel
%set waitbar
h = waitbar(0,'Calculating for testmodel...');
%Convert E-field data to RMS
Snapsize = size(testmodelSnapshot0,1);
Avg= ones(Snapsize,1);
for i= 1:size(testmodelSnapshot0,1)
    Avg(i) = sqrt((testmodelSnapshot0(i,1)^2 +
 testmodelSnapshot0(i,2)^2 + testmodelSnapshot0(i,3)^2)/2);
    waitbar(i / Snapsize)
end
close(h);
ImagAvg = imag(Avg);
%Pull up max data
m = testmodelm;
%Declare thresholds
t = m/2;
t2 = 50;
%Find total number of cells above threshold
count = 0;
count2 = 0;
for i=1:size(ImagAvg)
    if ImagAvg(i)>=t
        count = count+1;
    end
    if ImagAvg(i) >= t2
        count2 = count2+1;
    end
end
SurfacetestmodelVS = count/Snapsize;
SurfacetestmodelVS50 = count2/Snapsize;
clear i Avg count count2 ImagAvg Snapsize m t t2 h
disp('testmodel Completed...')
2%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%
%Record Data to Excel Sheet
VSdata =    {'Model','Volume Stimulated (%)';
             'Model M198451' SurfaceM198451VS;};
VS50data =    {'Model','Volume Stimulated (%)';
             'Model M198451' SurfaceM198451VS50;};
filename = 'Varying MRI Surface Data.xlsx';
xlswrite(filename,VSdata,1)
xlswrite(filename,VS50data,2)
Published with MATLAB® R2015a
Demyelinated Neurons: Electric Field and White Matter
The following pages show Sim4Life calculations of electric field values on the cortical surface and
corresponding magnetic field on TMS coil surface.
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Max E-field on WM Surface B-field on Coil Surface
0 0
3.36 0.0572
6.72 0.114
10.1 0.172
13.4 0.229
16.8 0.286
20.2 0.343
23.5 0.4
26.9 0.458
30.2 0.515
33.6 0.572
36.952 0.629283636
40.31090909 0.686494545
43.66981818 0.743705455
47.02872727 0.800916364
50.38763636 0.858127273
53.74654545 0.915338182
57.10545455 0.972549091
60.46436364 1.02976
63.82327273 1.086970909
67.18218182 1.144181818
70.54147186 1.201392727
73.9004329 1.258603636
77.25939394 1.315814545
80.61835498 1.373025455
83.97731602 1.430236364
87.33627706 1.487447273
90.6952381 1.544658182
94.05419913 1.601869091
97.41316017 1.65908
100.7721212 1.716290909
104.1310823 1.773501818
107.4900433 1.830712727
110.8490043 1.887923636
114.2079654 1.945134545
117.5669264 2.002345455
120.9258874 2.059556364
124.2848485 2.116767273
127.6438095 2.173978182
131.0027706 2.231189091
134.3617316 2.2884
137.7206926 2.345610909
141.0796537 2.402821818
144.4386147 2.460032727
147.7975758 2.517243636
151.1565368 2.574454545
154.5154978 2.631665455
157.8744589 2.688876364
161.2334199 2.746087273
164.592381 2.803298182
167.951342 2.860509091
171.310303 2.91772
174.6692641 2.974930909
178.0282251 3.032141818
181.3871861 3.089352727
184.7461472 3.146563636
188.1051082 3.203774545
191.4640693 3.260985455
194.8230303 3.318196364
198.1819913 3.375407273
201.5409524 3.432618182
Demyelinated Neurons: Electric Field, Current, and
Magnetic Field
The following page shows calculations of electric field on cortical white matter, induced current
on neuron bodies, and corresponding magnetic field on TMS coil surface. Induced current was
calculated by using Eq. 48, and magnetic field was calculated using interpolation of previously
shown data.
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E-field required on axons Current (pA) B-field on Coil Surface
0 0 0
32 10000 0.545176471
64 20000 1.089987178
96 30000 1.6350106
128 40000 2.180004189
160 50000 2.724988439
192 60000 3.26997269
224 70000 3.814956941
256 80000 4.359941191
288 90000 4.904925442
320 100000 5.449909692
Demyelinated Neurons: Python Script
The following pages include the python script from this project.
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Page 1/3/Users/hadimanilab/Documents/Farheen/NEST_Scripts/Demyelinated/demyelination.py
Saved: 4/16/18, 2:19:48 PM Printed for: hadimanilab
#Farheen Syeda1
#NEST Neural Simulator2
3
#add path where nest module is located to allow importing4
import sys5
sys.path.append('/Users/hadimanilab/opt/nest/lib/python2.7/site-packages')6
7
import matplotlib8
matplotlib.use('TKAgg')9
import pylab10
import nest11
import nest.topology as topp12
import numpy as np13
import array14
import matplotlib.pyplot as plt15
import matplotlib.animation as animation16
import mpl_toolkits.mplot3d.axes3d as p317
18
nest.ResetKernel()19
20
#define all constants here21
popnum = 1000 #number of neurons in stimulated population22
noise_ex_rate = 80000.0 #rate of incoming excitatory signal23
noise_in_rate = 15000.0 #rate of incoming inhibitory signal24
noise_ex_weight = 1.2 #synaptic weight of excitatory signal(pA)25
noise_in_weight = -2.0 #synaptic weight of inhibitory signal(pA)26
normal_V = -70.0 #normal resting potential of neurons (V)27
normal_E = -70.0 #normal starting potential of neurons (V)28
normal_C = 250.0 #normal capacitance of neurons (pF)29
30
sampling_resolution = 1. #for voltmeter (ms)31
stimamp = 0.0 #amplitude of stimulating current for TMS32
stimfreq = 2500.0 #frequency of TMS current (Hz)33
34
35
#Define stimulation parameters and create neurons36
normparams = {"C_m":normal_C}37
38
pop1 = nest.Create("iaf_neuron",popnum,{"C_m":280.0})39
pop2 = nest.Create("iaf_neuron",popnum,{"C_m":285.0})40
pop3 = nest.Create("iaf_neuron",popnum,{"C_m":290.0})41
vm_pars = {42
'record_to': ['memory'],43
'withtime':  True,44
'withgid':   True,45
'interval':  sampling_resolution46
}47
48
#Create devices for signal measurement49
vm = nest.Create('voltmeter',1,vm_pars)50
spikedetector = nest.Create("spike_detector",51
params={"withgid":True, "withtime":True}) #record spiking events52
vm2 = nest.Create('voltmeter',1,vm_pars)53
spikedetector2 = nest.Create("spike_detector",54
params={"withgid":True, "withtime":True}) #record spiking events55
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vm3 = nest.Create('voltmeter',1,vm_pars)56
spikedetector3 = nest.Create("spike_detector",57
params={"withgid":True, "withtime":True}) #record spiking events58
59
#Create stimulation device60
#Each pulse lasts for 0.4 miliseconds61
stim = nest.Create('ac_generator', params = {'amplitude':stimamp, 62
'frequency':stimfreq,63
'start':0.,64
'stop':0.4,65
'origin':0.})66
67
#Create poisson generator (generally used to model noisy neuron signals)68
noise_ex = nest.Create("poisson_generator")69
noise_in = nest.Create("poisson_generator")70
nest.SetStatus(noise_ex, {"rate":noise_ex_rate})71
nest.SetStatus(noise_in, {"rate":noise_in_rate})72
73
#Make noise connections to all populations74
75
nest.Connect(noise_ex, pop1, syn_spec={"weight":noise_ex_weight})76
nest.Connect(noise_in, pop1, syn_spec={"weight":noise_in_weight})77
78
nest.Connect(noise_ex, pop2, syn_spec={"weight":noise_ex_weight})79
nest.Connect(noise_in, pop2, syn_spec={"weight":noise_in_weight})80
81
nest.Connect(noise_ex, pop3, syn_spec={"weight":noise_ex_weight})82
nest.Connect(noise_in, pop3, syn_spec={"weight":noise_in_weight})83
84
#Connect stimulation sources to populations85
nest.Connect(stim,pop1)86
nest.Connect(stim,pop2)87
nest.Connect(stim,pop3)88
89
#Connect sources to readers90
nest.Connect(vm, pop1)91
nest.Connect(pop1, spikedetector)92
nest.Connect(vm2, pop2)93
nest.Connect(pop2, spikedetector2)94
nest.Connect(vm3, pop3)95
nest.Connect(pop3, spikedetector3)96
97
98
#Simulate 10 times for 100 ms each99
#10 pulses, 1000 ms = 1 second100
for k in range(10):101
nest.Simulate(100)102
print k+1103
print "..."104
105
#Signal analysis106
Vm = nest.GetStatus(vm, 'events')[0]['V_m']107
times = nest.GetStatus(vm, 'events')[0]['times']108
senders = nest.GetStatus(vm, 'events')[0]['senders']109
dSD = nest.GetStatus(spikedetector,keys="events")[0]110
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evs = dSD["senders"]111
ts = dSD["times"]112
113
Vm2 = nest.GetStatus(vm2, 'events')[0]['V_m']114
times2 = nest.GetStatus(vm2, 'events')[0]['times']115
senders2 = nest.GetStatus(vm2, 'events')[0]['senders']116
dSD2 = nest.GetStatus(spikedetector2,keys="events")[0]117
evs2 = dSD2["senders"]118
ts2 = dSD2["times"]119
120
Vm3 = nest.GetStatus(vm3, 'events')[0]['V_m']121
times3 = nest.GetStatus(vm3, 'events')[0]['times']122
senders3 = nest.GetStatus(vm3, 'events')[0]['senders']123
dSD3 = nest.GetStatus(spikedetector3,keys="events")[0]124
evs3 = dSD3["senders"]125
ts3 = dSD3["times"]126
127
#ts contains a list of all the timesteps in which a spike is recorded128
#the length of ts tells us the total number of impulses recorded129
print len(ts)130
print len(ts2)131
print len(ts3)132
133
134
135
136
Motor Pathway Model: Python Script
The following pages include the python script for the motor pathway model.
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#Farheen Syeda1
#NEST Neural Simulator2
#Motor Pathway model3
#Last Modified April 13, 2018 by Farheen Syeda4
5
6
#add path where nest module is located to allow importing7
import sys8
sys.path.append('/Users/hadimanilab/opt/nest/lib/python2.7/site-packages')9
import matplotlib10
matplotlib.use('TKAgg')11
import pylab12
import nest13
import nest.topology as topp14
import numpy as np15
import array16
import nest.voltage_trace17
import random18
import pylab as plt19
import csv20
import nest.raster_plot21
import matplotlib.pyplot as plt22
import matplotlib.animation as animation23
import mpl_toolkits.mplot3d.axes3d as p324
from random import randint25
from collections import Counter26
27
28
29
#Reset simulations30
nest.ResetKernel()31
nest.ResetNetwork()32
33
#Define Constants34
popnum = 10 #Number of neurons we want to follow through circuit35
iterations = 1 #Number of iterations for simulation to run36
simtime = 1500 #time in ms for simulation to run37
n = 8 #total number of neural layers in circuit38
39
#Create arrays for data storage40
pop = [0]*n41
multimeter = [0]*n42
spikedetector = [0]*n43
dmm = [0]*n44
Vms = [0]*n45
tss = [0]*n46
Vm = [0]*n47
times = [0]*n48
senders = [0]*n49
dSD = [0]*n50
evs = [0]*n51
ts = [0]*n52
ts10 = [0]*n53
lentsarray = [0]*iterations54
tsarray = [[] for i in range(n)]55
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poisson_ex = [0]*1056
poisson_in = [0]*1057
58
59
#Create TMS model60
TMSstimfreq = 2500.0 #frequency of TMS current (Hz)61
#Change TMSfreq to frequency of pulses/sec wanted62
TMSfreq = 10 #number of pulses/sec63
TMSpulsewidth = 0.4 #pulse width in ms64
TMS = [0]*TMSfreq #Create array for data storage65
b = simtime/TMSfreq66
TMSpause = b*1.0 #pause between TMS pulses (ms)67
stimamp = 40000.0 #amplitude of stimulating current for TMS68
69
70
#DBS Probe Model71
DBSfreq = 185.0 #frequency of DBS current pulses/sec72
DBSfreqint = int(DBSfreq)73
DBSpulsewidth = 0.09 #pulse width (milliseconds)74
DBSamp = 100000000.0 #amplitude of DBS current (pA)75
pausetime = simtime/DBSfreq #time of pause between pulses76
DBS = [0]*DBSfreqint77
78
79
#Start loop80
for i in range(iterations):81
82
#reset simulations for cleanliness83
nest.ResetNetwork()84
nest.ResetKernel()85
86
87
#Create TMS simulator88
for t in range(0,TMSfreq):89
starttimeTMS = t*(TMSpause)90
stoptimeTMS = starttimeTMS + TMSpulsewidth91
TMS[t] = nest.Create('ac_generator', params = {'amplitude':stimamp, 92
'frequency':TMSstimfreq,93
'start':starttimeTMS,94
'stop':stoptimeTMS,95
'origin':0.})96
97
98
#Create DBS simulator99
for d in range(0,DBSfreqint):100
starttime = d*(DBSpulsewidth+pausetime)101
stoptime = starttime + DBSpulsewidth102
DBS[d] = nest.Create('dc_generator', params = {'amplitude': DBSamp, 103
'start':starttime,104
'stop':stoptime})105
106
107
108
109
#Create devices for signal measurement110
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for p in range(0,n):111
multimeter[p] = nest.Create("multimeter")112
#record each sampling with time and decide which variables to record113
nest.SetStatus(multimeter[p],{"withtime":True, 114
"record_from":["V_m"]}) 115
#record spiking events116
spikedetector[p] = nest.Create("spike_detector",117
params={"withgid":True, "withtime":True})118
119
120
#Create neuron populations121
pop[0] = nest.Create("iaf_neuron",800)122
pop[1] = nest.Create("iaf_neuron",800)123
pop[2] = nest.Create("iaf_neuron",800)124
pop[3] = nest.Create("iaf_neuron",800)125
pop[4] = nest.Create("iaf_neuron",800)126
pop[5] = nest.Create("iaf_neuron",800)127
pop[6] = nest.Create("iaf_neuron",800)128
pop[7] = nest.Create("iaf_neuron",800)129
130
131
#Rename populations132
CTX = pop[0]133
STRD1 = pop[1]134
STRD2 = pop[2]135
SNc = pop[3]136
GPi = pop[4]137
GPe = pop[5]138
STN = pop[6]139
THL = pop[7]140
141
142
#Create noise generators143
for p in range(0,10):144
poisson_ex[p] = nest.Create('sinusoidal_poisson_generator',145
        params={'rate': random.uniform(8300.0, 8500.0), 'amplitude': 50.0,146
                'frequency': 1.0, 'phase': 0.0,147
                'individual_spike_trains': True}) 148
poisson_in[p] = nest.Create('sinusoidal_poisson_generator',149
        params={'rate': random.uniform(2000.0, 2100.0), 'amplitude': 50.0,150
                'frequency': 1.0, 'phase': 0.0,151
                'individual_spike_trains': True}) 152
153
154
#Connect all random noise generators to each neuron in each population155
for c in range(0,10):156
nest.Connect(poisson_ex[c], STN, {'rule': 'fixed_indegree', 'indegree': 1}, 157
syn_spec = {"weight":1.15})158
nest.Connect(poisson_in[c], STN, {'rule': 'fixed_indegree', 'indegree': 1}, 159
syn_spec = {"weight":-0.9})160
161
nest.Connect(poisson_ex[c], SNc, {'rule': 'fixed_indegree', 'indegree': 1}, 162
syn_spec = {"weight":1.0})163
nest.Connect(poisson_in[c], SNc, {'rule': 'fixed_indegree', 'indegree': 1}, 164
syn_spec = {"weight":-0.92})165
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166
nest.Connect(poisson_ex[c], STRD2, {'rule': 'fixed_indegree', 'indegree': 1}, 167
syn_spec = {"weight":1.0})168
nest.Connect(poisson_in[c], STRD2, {'rule': 'fixed_indegree', 'indegree': 1}, 169
syn_spec = {"weight":-0.85})170
171
nest.Connect(poisson_ex[c], STRD1, {'rule': 'fixed_indegree', 'indegree': 1}, 172
syn_spec = {"weight":1.0})173
nest.Connect(poisson_in[c], STRD1, {'rule': 'fixed_indegree', 'indegree': 1}, 174
syn_spec = {"weight":-1.1})175
176
nest.Connect(poisson_ex[c], GPe, {'rule': 'fixed_indegree', 'indegree': 1}, 177
syn_spec = {"weight":1.3})178
nest.Connect(poisson_in[c], GPe, {'rule': 'fixed_indegree', 'indegree': 1}, 179
syn_spec = {"weight":-0.5})180
181
nest.Connect(poisson_ex[c], GPi, {'rule': 'fixed_indegree', 'indegree': 1}, 182
syn_spec = {"weight":1.1})183
nest.Connect(poisson_in[c], GPi, {'rule': 'fixed_indegree', 'indegree': 1}, 184
syn_spec = {"weight":-1.4})185
186
nest.Connect(poisson_ex[c], CTX, {'rule': 'fixed_indegree', 'indegree': 1}, 187
syn_spec = {"weight":1.1})188
nest.Connect(poisson_in[c], CTX, {'rule': 'fixed_indegree', 'indegree': 1}, 189
syn_spec = {"weight":-1.28})190
191
nest.Connect(poisson_ex[c], THL, {'rule': 'fixed_indegree', 'indegree': 1}, 192
syn_spec = {"weight":1.97})193
nest.Connect(poisson_in[c], THL, {'rule': 'fixed_indegree', 'indegree': 1}, 194
syn_spec = {"weight":-1.0})195
196
197
198
#Connect DBS to GPi199
#Uncomment this section to connect DBS to GPi200
print "DBS Connected..."201
for d in range(0, DBSfreqint):202
nest.Connect(DBS[d],GPi)203
204
#Connect TMS to pop205
#Uncomment this section to connect TMS to CTX206
'''for d in range(0,TMSfreq):207
nest.Connect(TMS[d],pop[0])'''208
209
210
#Make connections between populations211
212
#Create synapse types213
#Cortex to Striatum214
nest.CopyModel("static_synapse","CTX2STRe",{"weight":0.1, "delay":5.1})215
#Substantia Nigra pars compacta to Striatum216
nest.CopyModel("static_synapse","SNc2STRe",{"weight":1.0, "delay":0.5})217
nest.CopyModel("static_synapse","SNc2STRi",{"weight":-5.0, "delay":0.5})218
#Striatum to GPi219
nest.CopyModel("static_synapse","STR2GPii",{"weight":-2.0, "delay":4.0})220
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#Striatum to GPe221
nest.CopyModel("static_synapse","STR2GPei",{"weight":-5.0, "delay":5.0})222
#GPe to STN223
nest.CopyModel("static_synapse","GPe2STNi",{"weight":-0.3, "delay":4.0})224
#Subthalamic Nucleus to GPi225
nest.CopyModel("static_synapse","STN2GPie",{"weight":1.2, "delay":1.5})226
#CTX to STN227
nest.CopyModel("static_synapse","CTX2STNe",{"weight":1.0, "delay":5.9})228
#STN to GPe229
nest.CopyModel("static_synapse","STN2GPee",{"weight":1.0, "delay":2.0})230
#GPe to GPi231
nest.CopyModel("static_synapse","GPe2GPie",{"weight":0.5, "delay":3.0})232
#GPi to THL233
nest.CopyModel("static_synapse","GPi2THLi",{"weight":-2.0, "delay":5.0})234
235
236
#Direct Pathway237
conn_CTX = {'rule': 'fixed_indegree', 'indegree': 800}238
nest.Connect(CTX,STRD1,syn_spec = "CTX2STRe", conn_spec = conn_CTX)239
nest.Connect(CTX,STRD2,syn_spec = "CTX2STRe", conn_spec = conn_CTX)240
nest.Connect(CTX,STN,syn_spec = "CTX2STNe", conn_spec = conn_CTX)241
242
#Funneling from Striatum onward243
conn_GPi = {'rule': 'fixed_indegree', 'indegree': 1000}244
nest.Connect(STRD1,GPi,syn_spec = "STR2GPii", conn_spec = conn_GPi)245
246
#Indirect Pathway247
#for c in range(200):248
conn_1 = {'rule': 'fixed_indegree', 'indegree': 800}249
nest.Connect(GPe,STN,syn_spec = "GPe2STNi", conn_spec = conn_1)250
nest.Connect(STN,GPi,syn_spec = "STN2GPie", conn_spec = conn_1)251
nest.Connect(STN,GPe,syn_spec = "STN2GPee", conn_spec = conn_1)252
nest.Connect(GPe,GPi,syn_spec = "GPe2GPie", conn_spec = conn_1)253
nest.Connect(GPi,THL,syn_spec = "GPi2THLi", conn_spec = conn_1)254
255
#Funneling from Striatum onward256
conn_GPe = {'rule': 'fixed_indegree', 'indegree': 800}257
nest.Connect(STRD2,GPe,syn_spec = "STR2GPei", conn_spec = conn_GPe)258
259
#Dopaminergic Input to Striatum260
#Comment this section out to model Parkinsonian circuitry261
'''conn_STR = {'rule': 'fixed_indegree', 'indegree': 1000}262
nest.Connect(SNc,STRD1, syn_spec = "SNc2STRe", conn_spec = conn_STR)263
conn_STRD2 = {'rule': 'fixed_indegree', 'indegree': 100}264
nest.Connect(SNc,STRD2,syn_spec = "SNc2STRi", conn_spec = conn_STRD2)'''265
266
267
268
269
#connect readers to populations270
for p in range(0,n):271
nest.Connect(multimeter[p], pop[p])272
nest.Connect(pop[p],spikedetector[p])273
274
275
Page 6/7/Users/hadimanilab/Documents/Farheen/NEST_Scripts/motor_pathway.py
Saved: 4/16/18, 2:18:00 PM Printed for: hadimanilab
#Simulate276
nest.Simulate(simtime)277
278
279
#Analysis280
for p in range(0,n):281
#obtain list of dictionaries for one node (index 0)282
dmm[p] = nest.GetStatus(multimeter[p])[0]283
#obtain data recorded for voltage and time284
Vms[p] = dmm[p]["events"]["V_m"]285
tss[p] = dmm[p]["events"]["times"]286
287
288
dSD[p] = nest.GetStatus(spikedetector[p],keys="events")[0]289
evs[p] = dSD[p]["senders"]290
ts[p] = dSD[p]["times"]291
292
293
#Print average firing rate for each nucleus to the screen294
print ""295
print "*********************"296
print ""297
298
print "SNc:",len(ts[3])/800299
print "CTX:",len(ts[0])/800300
print "STRD1:",len(ts[1])/800301
print "STRD2:",len(ts[2])/800302
print "GPi:",len(ts[4])/800303
print "GPe:",len(ts[5])/800304
print "STN:",len(ts[6])/800305
print "THL:",len(ts[7])/800306
307
c = Counter(ts[4])308
valuearray = c.values()309
print "Standard Deviation: ", np.std(valuearray)310
print "Mean: ", np.mean(valuearray)311
print "Max: ", max(valuearray)312
print "Min: ", min(valuearray)313
totalsignals = sum(c.values())314
print "Total Signals: ", totalsignals315
print "Number of active timesteps: ", len(c)316
317
print "Total number of timesteps: ", len(tss[4])318
319
320
print ""321
print "*********************"322
print ""323
324
325
#show raster plot326
nest.raster_plot.from_device(spikedetector[7], hist=False)327
pylab.show()328
329
330
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331
332
333
nest.ResetKernel()334
nest.ResetNetwork()335
336
